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The fusion of synaptic vesicles with the pre-synaptic plasma membrane is 
mediated by SNARE proteins. This work provides key insights into the behaviour of 
synaptobrevin, the SNARE protein localized to synaptic vesicles, in its native membrane 
organelle and when it is reconstituted in liposomes. The reactivity of reconstituted 
synaptobrevin has remained controversial. Recent studies have suggested that 
synaptobrevin inserted in membranes does not readily engage in SNARE complexes (Hu 
et al., 2002; Kweon et al., 2003b). I therefore explored the binding characteristics and 
assembly pathway of the SNAREs on synaptobrevin-bearing membranes. Like its soluble 
domain, synaptobrevin anchored in membranes binds to the syntaxin/SNAP-25 acceptor 
complex to form the stable tetra helical coiled coil SNARE bundle. Kinetic simulations 
and fitting of experimental data helped unravel the SNARE assembly pathway on 
membranes. Monitoring the effects of endogenous and extraneous factors on SNARE 
complex assembly suggested that assembly is a robust process, largely unaffected by 
brain cytosolic factors, membrane fluidity, chaotropicity, divalent ions and lipid 
composition but is considerably enhanced in the presence of weak counter-ions. In 
agreement with these observations, SNARE complex assembly rate on liposomes 
reconstituted with synaptobrevin and on synaptic vesicles was comparable.  
Being highly reactive molecules, the regulation of SNAREs has considerable 
importance. Synaptobrevin has been found to be associated in membranes with 
synaptophysin, an abundant protein localized to the synaptic vesicle and a potential 
regulator of SNARE complex assembly. I showed here that syntaxin/SNAP-25 binding to 
synaptobrevin in synaptic vesicles causes its dissociation from synaptophysin.  
Three monoclonal antibodies recognizing the ternary SNARE complex, but not the 
monomers, were successfully raised and characterised in immunoblots, cell-lines and 
plasma-membrane sheets. Their binding sites on the complex were mapped. In a 
functional assay, the antibodies abolished disassembly of the SNARE complex thus 
providing insights into the disassembly machinery.  
The antibodies can be used in other functional assays to answer pertinent 
questions. The status and dynamics of SNARE complexes was probed in pre-synaptic 
nerve-terminals. I found that the amount of SNARE complex is comparable in resting and 
stimulated synaptosomes, suggesting that they rapidly disassemble immediately after 






organelles when monitored by direct imaging or immunoblotting, suggesting that rapid 
disassembly of the SNARE complex is not a pre-requisite for endocytosis, though it 






















































The predominant mechanism of information transfer between neurons occurs via 
the release of neurotransmitters at specialised sites called chemical synapses (Loewi, 
1921). A typical chemical synapse is defined by a pre- and a post-synaptic neuron 
separated by a 20-40 nm gap called the synaptic cleft (Kandel, 2000). Upon the arrival of 
an action potential and subsequent elevation of intracellular calcium concentration in the 
pre-synaptic nerve terminal, specialised organelles called synaptic vesicles laden with 
neurotransmitters fuse with the plasma membrane and release their content into the 
synaptic cleft (Katz, 1969). Neurotransmitters diffuse across the synaptic cleft and bind to 
post-synaptic receptors, thereby eliciting specific post-synaptic responses, reviewed in 
(Sheng and Kim, 2002). 
The merger of synaptic vesicles with the presynaptic plasma membrane is a 
temporally – occuring at sub-millisecond time-scale - and spatially regulated process 
(Rettig and Neher, 2002; Rosenmund et al., 2003). Synaptic vesicles are targeted to 
specialised electron dense sites called ‘active zones’ on the presynaptic plasma membrane 
(Akert, 1971) and primed into a ‘release-ready’ state prior to calcium entry into the pre-
synaptic bouton (Rettig and Neher, 2002). Fusion occurs by membrane contact, merger, 
and the opening of an aqueous fusion pore (Jahn et al., 2003). The merging of two 
membranes involves their deformation and proceeds via low-energy intermediates 
(Kuzmin et al., 2001) which may be overcome by fluctuations and perturbations in the 
local lipid environment (Jahn and Grubmuller, 2002). Concomitant with activity-
dependent exocytosis, spontaneous fusion or miniature release events (minis) have been 
observed in neurons (Katz and Thesleff, 1957). In all biological fusion reactions, proteins 
have been suggested to bring into close apposition two disparate membranes and by their 
perturbation, thought to catalyze fusion (Jahn and Grubmuller, 2002). Such a role has 
been suggested for the SNARE proteins (Hanson et al., 1997; Lin and Scheller, 1997). 
SNARE proteins mediate all vesicular fusion events within the cell, with a few 
notable exceptions, among them that of miochondria (Griffin et al., 2006), sperm-egg 
fusion (Inoue et al., 2005) and virus entry into host cell, reviewed in (Jahn et al., 2003). 
Insights into the involvement of SNAREs in membrane trafficking in yeast led to the view 
that intracellular fusion events require engagement of SNAREs in transport vesicles (v-






functional importance of synaptic SNAREs was first demonstrated in studies showing 
them to be targets of clostridial neurotoxins (Blasi et al., 1993; Blasi, 1993; Heiner 
Niemann, 1994; Link et al., 1992; Schiavo et al., 1992), which block neuronal exocytosis. 
Mutational studies in Drosophila (Broadie, 1995; Fergestad et al., 2001; Schulze et al., 
1995), C. elegans (Nonet et al., 1998; Richmond et al., 2001) and mice (Schoch et al., 
2001; Washbourne et al., 2002) further demonstrated the significance of synaptic 
SNAREs in evoked release. Furthermore, SNAREs reconstituted in liposomes were able 
to fuse them (Schuette et al., 2004; Tucker et al., 2004; Weber et al., 1998), suggesting 
that SNAREs comprise the minimal fusion machinery.  
1.1 Neuronal SNAREs 
 
    SNAREs are characterised by 60-70 amino acids arranged in heptad repeats, 
termed SNARE motifs, which have a high tendency to form coiled coils (Fasshauer et al., 
1997b). The SNAREs involved in neuronal exocytosis are syntaxin 1, synaptobrevin 2 
and SNAP-25 (Fig. 1a). These three proteins assemble spontaneously into a complex that 
sediments at 7 S (Sollner et al., 1993a). 
Synaptobrevin or VAMP (Vesicle associated membrane protein) is a 12.5 kDa 
(116 amino acids) type 2 membrane protein, confined to synaptic vesicles (Baumert, 1989 
; Trimble et al., 1988). Two isoforms, synaptobrevin 1 and synaptobrevin 2 are known to 
be differentially expressed in the nervous system (Raptis et al., 2005). In this work, 
synaptobrevin 2 shall be referred to as simply synaptobrevin. Synaptobrevin has a short 
unstructured N-terminal region (Fig. 1a), (Hazzard et al., 1999) which, in its homologs, is 
either absent or replaced by a folded N-terminal profilin-like domain referred to as the 
longin domain (Gonzalez et al., 2001; Tochio et al., 2001). The cytoplasmic domain 
contains one SNARE motif which was determined to be unstructured in solution by 
circular dichroism (Fasshauer et al., 1997b) and solution state NMR studies (Hazzard et 
al., 1999). 
Syntaxin 1, a 33 kDa (288 amino acids) type 2 membrane protein, is localized to 
the pre-synaptic plasma membrane (Bennett, 1992   ). Two isoforms, syntaxin 1a and 
syntaxin 1b with 84% sequence homology are differentially expressed in the central and 
peripheral nervous systems (Ruiz-Montasell, 1996 ). In this work, syntaxin 1a shall be 







bundle called the Habc domain (aa 24-150) linked to a single SNARE motif by a flexible 
linker (Margittai et al., 2003a). X-ray and NMR structures of the Habc domain suggest that  
it is well structured with three alpha helices (Fernandez et al., 1998; Lerman et al., 2000) 
(Fig 1a). The groove between the second and the third helix is conserved. Though 
unstructured in solution, the SNARE motif of syntaxin tends to adopt a homotetrameric 




Figure 1. SNARE domains and structures 
a) The amino terminal domain of syntaxin (Habc) forms a three helical bundle (PDB 1EZ3); 
(Lerman et al., 2000). The SNARE motifs of syntaxin, synaptobrevin and SNAP-25 form 
a four helical coiled coil structure (PDB 1SFC);(Sutton et al., 1998). Synaptobrevin 
contains an N-terminal proline-rich amino terminal (N). Notice that whereas both syntaxin 
and synaptobrevin contain a trans-membrane region (TMR), SNAP-25 attaches to the 
membrane through the palmitoylation anchors at the four cysteine residues in the central 
domain between the two SNARE motifs. 
b) Schematic drawing of the neuronal SNARE complex showing the layers -7 to +8; 0 layer 
in red, -1, +1, +2 in blue and all the other layers in black. Fig. b was reproduced from 








SNAP-25 (synaptosome-associated protein of 25 kDa, 206 amino acids) (Oyler et al., 
1989) contains two SNARE motifs which are associated with the presynaptic plasma 
membrane via palmitoyl chains on the linker between the SNARE motifs (Fig. 1a) (Hess 
et al., 1992). Two splice variants, SNAP-25a and SNAP-25b which differ in only nine 
amino acids are known (Bark et al., 1995). In this study, SNAP-25a shall be referred to as 
simply SNAP-25. Circular dichrosim (CD) experiments have shown that isolated SNAP-
25 is unstructured in solution (Fasshauer et al., 1997b). 
In isolation, the SNAREs are mainly unstructured but upon contact with each 
other, their SNARE motifs spontaneously assemble in parallel into a twisted, tight, tetra-
helical coiled coil bundle (ternary complex) of very high kinetic stability (Fig. 1a) 
(Fasshauer et al., 2002; Fasshauer et al., 1997b; Sutton et al., 1998). Whereas syntaxin 
and synaptobrevin contribute one helix each to the ternary complex, SNAP-25 contributes  
two helices. Four mainly hydrophobic residues, one from each of the SNARE motifs 
interact at sixteen positions in the interior of the structure (Sutton et al., 1998). These 
positions are referred to as layers numbered from -7 to +8 (Fig. 1b). The helix bundle is 
largely stabilised by these hydrophobic interactions. The 0-layer, unlike the other layers is 
not comprised of hydrophobic residues; instead, three glutamines (Q), contributed by 
syntaxin and SNAP-25 and one arginine (R), contributed by synaptobrevin interact to 
form a polar layer. The polar layer co-ordinates a H2O molecule (Brunger and Ernst, 
2002). The 3Q:1R topology is conserved in other SNARE complexes (Antonin et al., 
2002b; Pobbati et al., 2004). Based on these observations, the SNAREs were reclassified 
as Q- and R- SNAREs (Fasshauer et al., 1998b). The Q-SNAREs were further classified 
as Qa-, Qb- and Qc- SNAREs (Bock et al., 2001). Syntaxin homologs were classified as 
Qa-SNAREs, and SNAP-25 helix 1 and helix 2 homologs were classified as Qb- and Qc- 
SNAREs respectively. It was proposed that a fusion competent SNARE complex must 
contain a Qa, Qb, Qc, R combination (Bock et al., 2001; Fasshauer et al., 1998b). 
Mutagenesis studies have confirmed that a 3Q:1R configuration is required for functional 
SNARE complexes (Graf et al., 2005; Katz and Brennwald, 2000; Ossig et al., 2000). The 
Q and R system of nomenclature has proven to be more accurate than the t- and v- system 
of nomenclature since many t-SNAREs are found in vesicles and v-SNAREs are found on 
target membranes (Cao and Barlowe, 2000; Liu and Barlowe, 2002). Likewise, the Q and 







1.2 SNARE Assembly 
 
The proposal that the energy released during SNARE complex formation is 
sufficient to induce fusion is supported by molecular dynamics simulation studies 
indicating that the energy of about 3-8 kcal/mol of unstructured SNAREs could be 
transduced cooperatively by the linker region of syntaxin (Knecht and Grubmuller, 2003) 
trespassing low-energy intermediates on way to fusion (Kuzmin et al., 2001). The 
extraordinary stability of the SNARE complex (Fasshauer et al., 2002) lends credence to 
the view that the energy of fusion is derived from SNARE complex formation. These 
findings, together with genetic (Broadie, 1995; Fergestad et al., 2001; Nonet et al., 1998; 
Richmond et al., 2001; Schoch et al., 2001; Schulze et al., 1995; Washbourne et al., 
2002), biochemical (Blasi et al., 1993; Blasi, 1993; Heiner Niemann, 1994; Link et al., 
1992; Schiavo et al., 1992; Schuette et al., 2004; Tucker et al., 2004; Weber et al., 1998) 
and physiological studies (Nagy et al., 2004; Sakaba et al., 2005; Sorensen et al., 2002; 
Wei et al., 2000; Xu et al., 1999) hint strongly at SNAREs being putative fusogens. 
The Habc domain of syntaxin, folds back on its SNARE motif in what is known as 
the closed conformation of syntaxin (Chen and Scheller, 2001). This conformation is 
stabilised by a protein called Munc18-1 or nSec1, a key regulatory protein in neuronal 
exocytosis (Dulubova et al., 1999; Misura et al., 2000). The closed conformation of 
syntaxin reduces the interaction of its SNARE motif with that of synaptobrevin and 
SNAP-25 (Margittai et al., 2003b). In in vitro experiments, the removal of the Habc 
domain accelerates the rate of SNARE complex formation ten-fold (Margittai et al., 
2003c). The Habc domain does not interact tightly with the SNARE complex as evinced by 
thermal denaturation experiments (Fasshauer et al., 1997b; Karin L. Nicholson, 1998; 
Rice et al., 1997). Furthermore, the linker between the Habc domain and the SNARE motif 
of syntaxin was shown to be highly flexible when syntaxin was engaged in SNARE 
complexes (Margittai et al., 2003a). Moreover, in yeast, when the Q-SNARE complex is 
made intramolecular, the Habc domain of the yeast plasma membrane syntaxin, Sso1p, is 
not required for efficient SNARE complex formation (Van Komen et al., 2006). These 
findings suggest that once SNARE complexes have formed, the Habc domain acts 








1.2.1 Intermediates in the assembly pathway of SNAREs 
 
Synaptic SNAREs have been found to interact with each other in a variety of 
combinations. Only a subset of these interactions probably represents biologically 
relevant intermediates.  
The binding affinity between syntaxin and SNAP-25 has been determined to be 
high (Pevsner et al., 1994), whereas that between syntaxin and synaptobrevin is weak 
(Calakos et al., 1994).  Indeed, thermal denaturation of the SNARE complex followed by 
renaturation revealed that the assembly pathway of the ternary SNARE complex transits 
through a less stable intermediate (Fasshauer et al., 2002). This intermediate was found to 
be a binary complex between syntaxin and SNAP-25. The distinct hysteresis profile for 
SNARE diassembly and assembly follows from the fact that the system does not remain 
in thermodynamic equilibrium at any given time. Therefore free energy changes involved 
in SNARE complex assembly have not been possible to measure. The studies by 
Fasshauer and colleagues (Fasshauer et al., 2002) estimate the rate of SNARE complex 
disassembly to be as slow as 4 x 10-18 s-1. Such a large kinetic barrier suggests that certain 
factors are required for disassembly so that the SNAREs can be reused in subsequent 
rounds of fusion. Indeed, several lines of evidence show NSF, a homo-hexameric protein 
complex belonging to the AAA+ family of ATPases, in conjuction with its cofactor α-
SNAP to be involved in the disassembly process (Horsnell et al., 2002; Littleton et al., 
1998; Pallanck et al., 1995; Sollner et al., 1993a; Sollner et al., 1993b; Whiteheart et al., 
1993).  
In solution, syntaxin and SNAP-25 interact to assume a coiled coil domain 
structure, as assessed by the increase in alpha helicity in CD experiments (Fasshauer et 
al., 1997a). The stoichiometry of syntaxin and SNAP-25 in a complex was determined to 
be 2:1 in experiments comprising non-denaturing and denaturing PAGE (Fasshauer et al., 
1997b).  
The structure of the complex between syntaxin and SNAP-25 is a parallel four 
helix bundle like the ternary SNARE complex, with one of the syntaxins occupying the 
binding site for synaptobrevin (Margittai et al., 2001; Xiao et al., 2001). In addition to the 
2:1 syntaxin/SNAP-25 heterodimer, the SNARE motif of syntaxin can form a 
homotetramer of two pairs of parallel helices arranged in an anti-parallel configuration 
(Misura et al., 2001b) and a  four helix bundle with only the first half of SNAP-25 






also observed in live endocrine cells using fluorescently tagged versions of the proteins 
(An and Almers, 2004). The biological significance of homo- and hetero- oligomeric 
forms of syntaxin is not known.  
These off-pathways, however, do complicate studies of the bona fide assembly 
pathway of the ternary SNARE complex, which proceeds via a 1:1 syntaxin/SNAP-25 
complex, an intermediate to which a synaptobrevin molecule can readily bind (Fasshauer 
and Margittai, 2004). The binding mode of synaptobrevin to the 1:1 syntaxin/SNAP-25 
heterodimer has been difficult to assess due to the transient nature of this intermediate: the 
formation rate of the syntaxin/SNAP-25 1:1 dimer has been determined to be a second 
order rate constant of 6000 M-1-s-1 (Fasshauer and Margittai, 2004) and koff for this 
product is estimated to be 0.01 s-1 (Dirk Fasshauer, unpublished observations). The 
assembly of SNAREs has been suggested to commence at the N-terminal ends of the 
molecules – according to the so-called N-terminal zippering model (Hanson et al., 1997; 
Lin and Scheller, 1997).  
 
1.2.2 N-terminal zippering model of SNARE complex assembly 
 
Both synaptobrevin and syntaxin are type II membrane proteins and SNAP-25 is 
attached to the plasma membrane via its palmitoyl linkers. Hence it is conceivable that 
their `zippering´ from the N-terminal to the C-terminal ends would bring the synaptic 
vesicle in close proximity to the plasma membrane. The energy of complex assembly 
would then be transduced via the membrane proximal linker to the local lipid environment 


















Figure 2. Putative model for SNARE mediated membrane fusion. 
Syntaxin (red) and SNAP-25 (green) on the plasma membrane form an acceptor site for binding of 
synaptobrevin (blue). Binding of synaptobrevin to the syntaxin/SNAP-25 acceptor complex  
beginning at the N-terminal end brings the neurotransmitter-laden synaptic vesicle and the plasma 
membranes in close apposition. The energy released in complex formation is transduced to the 
membranes, perturbing them and thereby causing fusion. 
 
It has been suggested that a 1:1 heterodimer between syntaxin and SNAP-25 is first 
formed as an intermediate to which synaptobrevin binds and zippers from the N-terminal 
to the C-terminal end (Fasshauer and Margittai, 2004). Though attractive, this model has 
not been directly proven. Several indirect lines of evidence, however, exist for the model. 
First, the N-terminus of Sso1/Sec9p, yeast homolog of syntaxin/SNAP-25, is structured 
and provides an acceptor site for Snc1/2p, yeast homolog of synaptobrevin, which is 
suggested to bind to this N-terminus structured end and initiate zippering (Fiebig et al., 






are in leucine zipper proteins but frequently occur in the SNARE motif may form 
intermolecular hydrogen bonds that could assist in directed assembly (Antonin et al., 
2002b). Third, deuterium exchange on amides of synaptobrevin monitored by two 
dimensional NMR (1H15N TROSY-HSQC) suggests that the N-terminal half of the 
SNARE complex is more tightly packed than the C-terminal half (Chen et al., 2002). 
Fourth, in electrophysiological studies of adrenal chromaffin cells, a monoclonal antibody 
raised against the N-terminal end of SNAP-25 was shown to block complex formation 
(Xu et al., 1999). Fifth, fluorescence spectroscopy studies determined that whereas C-
terminal truncations of syntaxin and SNAP-25 do not block assembly, the N-terminal 
truncations abolish assembly (Fasshauer and Margittai, 2004). Sixth, toxin cleavage 
analysis in crayfish neurons indicated that the N-terminal end of synaptobrevin is shielded 
in a complex (Hua et al., 1998). Seventh, studies involving mutation of SNAREs in 
cracked PC-12 cells suggest a sequential assembly of SNAREs starting from the N-
terminal end (Chen et al., 2001).  
Two modes of SNARE assembly starting from the N-terminal end are 
conceivable. One, once assembly starts, it zippers down all the way to the C-terminal end, 
transducing all the energy contained in the unfolded SNARE monomers to the lipids, 
causing fusion. This implies that the SNAREs would have to be prevented from making 
contacts before the calcium trigger to avoid undesirable fusion events. Two, assembly 
comes to a halt mid-way resulting in partially zippered complexes, probably stabilised by 
repulsive forces of the membranes or by other proteins. Upon calcium elevation, SNARE 
complex assembly would zipper to completion resulting in fusion. Either way, evoked  
neurotransmitter release is under the control of several auxiliary factors and hence 
intricately regulated. 
1.3 Regulation of SNARE-mediated membrane fusion 
 
A fundamental question in the field is how the highly reactive SNAREs are 
controlled to ensure that fusion occurs at a defined location and with defined kinetics. It is 
conceivable that the regulation of SNARE-mediated fusion of synaptic vesicles with 
plasma membranes may occur at any stage in the vesicle exo-endocytosis cycle. Though 
not known, it is possible that the level and activity of regulators is controlled by supra-
regulatory mechanisms, which would indirectly affect SNARE activity. Also, it cannot be 






SNAREs by NSF/α-SNAP, thereby controlling the rate of vesicle recycling. The other 
possibilities are that SNAREs are directly acted upon by other factors. Two ways are 
conceivable in which SNAREs are directly controlled. One, the assembly of SNAREs 
may be blocked by a calcium sensor after partial zippering has occurred. An elevation of 
intracellular calcium would relieve this block causing fusion. Two, the SNAREs may be 
kept from interacting with each other by various factors thereby regulating the number of 
fusion-competent vesicles or number of sites on the active zone capable of supporting 
fusion. Some of the ways by which vesicle fusion may be regulated are discussed below.  
 
1.3.1 Regulation by disassembly 
 
SNARE complexes, being kinetically trapped (Fasshauer et al., 2002), need to be 
disassembled for reuse of the individual monomers. Co-sedimentation experiments 
revealed a 20S complex comprising one SNARE complex, three alpha SNAPs and one 
hexameric NSF, (Wimmer et al., 2001). It is generally believed that NSF and its cofactor, 
α-SNAP constitute the disassembly machinery (Chen and Scheller, 2001; Jahn et al., 
2003). Drosophila with a temperature-sensitive allele for NSF undergo a slow onset of 
paralysis when they were subjected to heat shock at 38oC (Pallanck et al., 1995). This 
slow onset of paralysis is probably due to unavailability of free monomeric SNAREs for 
subsequent rounds of fusion. It is therefore conceivable, though not established, that under 
physiological conditions, the activity of NSF and/or α-SNAP is altered to modulate the 
availability of free SNAREs. 
 
1.3.2 Regulation by the calcium sensor 
 
Neuro-exocytosis, being a calcium-mediated process, requires a calcium sensor. 
One of the original proposals was that this trigger is intrinsic to the SNARE complex. 
Though two sites on the surface of the SNARE complex formed by acidic and hydrophilic 
residues on SNAP-25 (D85/E170/Q177) and synaptobrevin (S75/E78/T79) were found to 
co-ordinate divalent ions in neuronal SNARE complex (Sutton et al., 1998), further 
evidence, including NMR and modelling studies, have discounted the direct binding and 
calcium-triggering role of SNARE complex (Chen et al., 2005; Rickman et al., 2004). In 
the search for a putative calcium sensor, much attention has shifted to a 65 kDa protein 






 vesicles and large dense core vesicles, reviewed in (Chapman, 2002). Synaptotagmin 
binds to calcium via its C2 domains at an affinity at which neuro-exocytosis occurs 
(Brose et al., 1992; Davis et al., 1999). Mice carrying mutation in the synaptotagmin I 
gene have severely impaired neurotransmitter release  and die within 48 hours of birth 
(Geppert et al., 1994). Synaptotagmin has been shown to bind to phospholipids in a 
calcium dependent manner (Brose et al., 1992; Shin et al., 2003) and to SNAREs in 
calcium-dependent and independent manners (Bai et al., 2004; Chapman et al., 1995; 
Rickman and Davletov, 2003). Various hypotheses exist on the mode of synaptotagmin 
action. One possibility is that it clamps SNARE complexes from fully zippering. Upon 
calcium influx, the block would be released, which would enable full SNARE pairing. 
Another possibility is that upon calcium elevation, synaptotagmin binds SNARE complex 
and phospholipids simultaneoulsy and mediates membrane fusion in concert with 
SNAREs. The exact mode of syaptotagmin action is yet to be elucidated.  
 
1.3.3 Regulation of Syntaxin 
 
 As discussed above, syntaxin switches between its open and closed conformation. 
Single molecule fluorescence studies estimated the time for this switch to be 0.8 ms 
(Margittai et al., 2003b). Syntaxin, in its closed conformation, binds to Munc18-1 which 
therefore has been suggested to control the availability of syntaxin for SNARE complex 
formation (Dulubova et al., 1999). Another protein, Munc13-1, has been suggested to 
mediate the release of syntaxin from the Munc18-1 block (Betz et al., 1997; Sassa et al., 
1999). Mice deficient in the gene for either Munc18-1 or Munc13-1 show complete block 
in neurotransmitter release (Augustin et al., 1999; Verhage et al., 2000). Though these 
findings directly confirm the indispensable role of Munc18-1 and Munc13-1 in neuronal 
exocytosis, they are hard to reconcile with the proposed inhibitory block of syntaxin by 
Munc18-1. Though Munc13-1 has been proposed to prime the SNAREs for fusion 
(Rosenmund et al., 2003), its interaction with calmodulin has been implicated in 
modulating short-term plasticity (Junge et al., 2004). A possible mechanism by which 
syntaxin activity could be modulated is by its N-terminal Habc domain. But apart from the 
folding of this domain on to the syntaxin SNARE motif (Dulubova et al., 1999), no role 








1.3.4 Regulation of SNAP-25 
 
      As described above, SNAP-25 has four palmitoylation anchors in the linker between 
the two SNARE motifs. Plasma membrane targeting of SNAP-25 by the palmitoylation 
anchors increases its local concentration and is necessary for SNARE complex formation. 
(Koticha et al., 2002). It has been suggested that the local concentration of SNAP-25 on 
the plasma membrane is controlled by rounds of palmitoylation and depalmitoylation as 
SNAP-25 in PC-12 cells and neurites was suggested to be dynamically palmitoylated 
(Hess et al., 1992; Lane and Liu, 1997). Furthermore, phosphorylation and 
dephosphorylation of SNAP-25 at Thr138 and Ser187 was found to be necessary to 
modulate the number of vesicles in the release-ready state (Nagy et al., 2002; Nagy et al., 
2004), adding another level of complexity in regulation.  
1.4 Emerging role of synaptobrevin in regulation  
 
Over the years, it has emerged that synaptobrevin, predominantly resident on the 
synaptic vesicles, is under exquisite control. There are on an average 60-70 synaptobrevin 
molecules on a single synaptic vesicle (Takamori unpublished observations). To 
orchestrate the reactivity of such a large number of synaptobrevin molecules, several 
modes of regulation have probably evolved. In this section, the possible ways in which 






















Figure 3. Status of synaptobrevin in membrane when not engaged in SNARE complex. 
Synaptobrevin (blue) may exist in one or more configurations illustrated above. 
a) The membrane proximal aromatic residues tryptophan 89 and 90 dip into the membrane 
and drive residues 85-92 into an amphipathic helix (two α-helical turns) at 33o to the 
membrane normal. Based on EPR accessibility measurements, this model was proposed 
by (Kweon et al., 2003a; Kweon et al., 2003b). 
b) Synaptobrevin dimerizes via its transmembrane regions. Based on site-directed 
mutagenesis experiments, Langosch and colleagues suggested the key eight residues 
(highlighted in the sequence) to be critical for synaptobrevin homodimerization (Laage 
and Langosch, 1997; Roy et al., 2004) 
c) Synaptobrevin may not prefer any particular configuration in the membrane but remains 
largely unconstrained.  
d) Synaptobrevin forms a labile heterodimer with synaptophysin 1 (Edelmann et al., 1995; 
Pennuto et al., 2002; Reisinger et al., 2004; Yelamanchili et al., 2005). This interaction 











1.4.1 Regulation by soluble synaptobrevin-like R-SNAREs 
  
  Two soluble R-SNAREs have been found to be enriched in the brain: tomosyn 
and amisyn. Tomsyn is a 130 kDa protein containing a C-terminal R-SNARE motif. It has 
been shown to form a tight ternary complex of very high kinetic stability with syntaxin 
and SNAP-25 (Hatsuzawa et al., 2003; Pobbati et al., 2004). The crystal structure of this 
complex was solved (Pobbati et al., 2004). It has a striking resemblance to the ternary 
complex with synaptobrevin. This complex can be disassembled by NSF and α-SNAP 
(Hatsuzawa et al., 2003). In several studies, tomosyn was proposed to be a positive 
regulator of exocytosis (Baba et al., 2005; Fujita et al., 1998). Other studies have assigned 
a negative regulatory role for tomosyn suggesting that it directly competes with 
synaptobrevin to form the fusion-inactive tomosyn SNARE complex and thus act as a 
negative regulator of exocytosis (Hatsuzawa et al., 2003; Widberg et al., 2003; Yizhar et 
al., 2004).  Amisyn is a 25 kDa protein and like tomosyn, it contains a C-terminal R-
SNARE motif. Whereas the SNARE motif of amisyn does not efficiently inhibit 
exocytosis, full-length amisyn can block secretion of growth hormone from PC-12 cells 
(Constable et al., 2005; Scales et al., 2002). Although amisyn can form ‘fusion 
incompetent’ complexes with syntaxin and SNAP-25, its inhibitory role is not due to its 
binding to syntaxin (Constable et al., 2005).  
 
1.4.2 The synaptophysin/synaptobrevin heterodimer 
 
 In the membrane of synaptic vesicles, synaptobrevin was shown to be associated 
with synaptophysin, a major multispanning membrane protein of synaptic vesicles (Fig 
3d) (Calakos and Scheller, 1994; Edelmann et al., 1995; Washbourne et al., 1995). 
Synaptophysin 1 and its homolog synaptogyrin 1 together account for about 10% of 
vesicular proteins (Jahn et al., 1985; Wiedenmann and Franke, 1985). In transfected PC-
12 cells, synaptophysin 1 and synaptogyrin 1 are potent inhibitors of exocytosis (Sugita et 
al., 1999) indicating a role for these proteins in regulating exocytosis. Interaction of 
synaptobrevin with synaptophysin and syntaxin 1/SNAP-25 is mutually exclusive 
(Edelmann et al., 1995), suggesting that release of synaptobrevin from synaptophysin may 
constitute an (additional) activation step (Pennuto et al., 2002; Reisinger et al., 2004; 
Yelamanchili et al., 2005). However, genetic ablation of synaptophysin results in no 





    
   Mice lacking the gene for both synaptophysin 1 and its homolog synaptogyrin 1 
have no visible phenotype but exhibit greatly attenuated long term potentiation (LTP) 
(Janz et al., 1999). Owing to the lack of visible phenotype in synaptophysin 1 or in both 
synaptophysin 1 and synaptogyrin 1 double knock-out mice, many researchers have  
questioned the functional role of these proteins in neuro-exocytosis. It is possible, though, 
that synaptophysin, via its interaction with synaptobrevin or another as yet unknown 
factor, may be involved in fine-tuning neuronal exocytosis under certain conditions. 
Further work needs to be done to elucidate the functional importance of such an abundant 
protein. 
 
1.4.3 Synaptobrevin dimerization 
 
Synaptobrevin can interact with different proteins with its different domains; 
whereas the SNARE motif interacts with syntaxin and SNAP-25 to form the ternary 
SNARE complex, the trans-membrane region has been suggested to interact with 
synaptophysin (Calakos and Scheller, 1994; Edelmann et al., 1995; Washbourne et al., 
1995). Under denaturing conditions, a distinct dimeric form of synaptobrevin is 
discernible in SDS-PAGE (Fig. 3b) (Edelmann et al., 1995). Mutational and cross-linking 
studies suggested that synaptobrevin dimerizes via its trans-membrane domain (Laage and 
Langosch, 1997; Roy et al., 2004). The functional relevance, if any, for synaptobrevin 
dimerization, could be in the proposed multimerization of the SNARE complex (Laage et 
al., 2000) or in being a transitory species from the synaptophysin/synaptobrevin 
heterodimer to the SNARE complex. Another study, however, estimated the dissociation 
constant of synaptobrevin dimerization to be 10 mM, questioning the significance of this 
association in vivo (Bowen et al., 2002). 
 
1.4.4 Regulation of synaptobrevin by Ca+2/calmodulin 
Initially calmodulin was suggested to be a candidate calcium sensor in neuro-
exocytosis (Burgoyne, 1984). However, the low off rate of Ca+2 dissociation from 
calmodulin cannot account for the transient nature of reponse to elevated calcium in nerve 
terminals (Teo and Wang, 1973). Another possible role suggested for Ca+2/calmodulin is 
its regulation of synaptobrevin in the late stage of exocytosis (De Haro et al., 2003). 
Ca+2/calmodulin has been reported to bind to synaptobrevin C-terminus (aa 77-90) with a 






µM (Quetglas et al., 2002). Synaptobrevin77-90 has also been suggested to bind to lipids 
(Quetglas et al., 2000). Using surface plasmon resonance spectroscopy (SPR) and epitope 
accessibility methods, it was suggested that Ca+2/calmodulin transfers this domain of 
synaptobrevin from the cis- to trans- bilayer (de Haro et al., 2004). In a functional assay 
designed to monitor human growth hormone release from PC-12 cells, Ophiobolin A, a 
calmodulin antagonist, significantly blocked release (Quetglas et al., 2002), raising the 
stakes for calmodulin as a regulator. Nonetheless, calmodulin is involved in a variety of 
cellular processes and it cannot be ruled out that exocytosis was affected indirectly. 
Various other roles for calmodulin in regulating exocytosis or modulating short term 
plasticity have been suggested. (Brooks and Treml, 1984; Chamberlain et al., 1995; Junge 
et al., 2004; Okabe et al., 1992). 
1.4.5 Regulation of synaptobrevin by the membrane 
 
In recent years, several reports have suggested that membrane-inserted 
synaptobrevin is refractory to SNARE complex assembly (Hu et al., 2002; Hu et al., 
2003; Kweon et al., 2003b). When isolated synaptic vesicles were incubated with 
recombinant SNAP-25 and syntaxin 1, no complex formation was observed. Synaptic 
vesicles did not fuse with liposomes reconstituted with syntaxin 1 and SNAP-25 unless 
calcium was added (Hu et al., 2002).  
Synaptobrevin in synaptic vesicles was also unable to engage with soluble 
syntaxin and SNAP-25 in a complex in the presence of calcium. It was therefore 
suggested that synaptobrevin requires interaction with the calcium sensor, synaptotagmin 
I, for activation to catalyze fusion (Hu et al., 2002). The reactivity of purified 
synaptobrevin was investigated after incorporation into liposomes by Electron 
paramagnetic resonance studies (Kweon et al., 2003b). No complexes formed with 
syntaxin 1 and SNAP-25, suggesting that synaptobrevin is intrinsically inactive when 
inserted into a bilayer. The lack of reactivity was attributed to the membrane-proximal 
region of synaptobrevin (aa 85-92) that is located adjacent to the transmembrane domain 
and includes the C-terminal end of the SNARE motif (Kweon et al., 2003b). This region 
was suggested to form an amphipathic helix that is tilted at an angle of 33°, with two 







the bilayer (Fig 3a) (Kweon et al., 2003a). When these Trp-residues were replaced with 
serine, SNARE binding was restored (Kweon et al., 2003b). These authors suggested that  
SNARE assembly is directly regulated by the membrane, mediated primarily by the 
membrane-proximal tryptophan residues.  
The data discussed above indicate that the SNARE motif of membrane-anchored 
synaptobrevin is normally inaccessible for complementary SNAREs, implying that 
synaptobrevin requires activation for fusion catalysis. However, synaptobrevin 
reconstituted in proteoliposomes readily fuses with liposomes containing syntaxin and 
SNAP-25 in a manner that is clearly dependent on the formation of SNARE complexes 
(Schuette et al., 2004; Tucker et al., 2004; Weber et al., 1998), a finding that is very 
difficult to reconcile with the notion that synaptobrevin is inaccessible in 
proteoliposomes. As discussed in section 1.2.2, in view of the widely believed N-terminal 
direction of SNARE assembly, the significance of the C-terminal restriction of 
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1.5 Aims of this study 
 
Chemical neurotransmission is an intricately regulated process. Synaptic vesicles 
filled with neurotransmitters fuse with the pre-synaptic plasma membrane with defined 
kinetics at specialised sites in the pre-synaptic nerve terminals called active zones. The 
most attractive candidates to execute fusion are the SNARE proteins (Chen and Scheller, 
2001; Jahn et al., 2003; Rizo and Sudhof, 2002). The SNAREs, syntaxin and SNAP-25 on 
the plasma membrane and synaptobrevin in the synaptic vesicle, spontaneously assemble 
in solution to form stable tetra-helical coiled coils. Determining the factors that 
temporally and spatially regulate these highly reactive molecules would considerably 
enhance understanding of the molecular mechanisms underlying neurotransmission.  
Synaptobrevin, the SNARE localized to the synaptic vesicles constitutes about 
10% of the total vesicular protein pool and is the favourite substrate of clostridial 
neurotoxins. Botulinum toxins B, D, F, G and Tetanus toxin selectively cleave 
synaptobrevin, reviewed in (Breidenbach and Brunger, 2005). Understanding the 
mechanisms and pathways in which synaptobrevin is regulated is essential for enhancing 
knowledge of not just neuronal exocytosis but pathological conditions arising from 
clostridial neurotoxin poisoning. Extensive work on the assembly pathway of soluble 
domains of SNAREs suggests that synaptobrevin readily binds to the syntaxin/SNAP-25 
acceptor complex (Fasshauer and Margittai, 2004). Is synaptobrevin in membrane as 
reactive as it is in solution? Several reports have suggested that reconstituted 
synaptobrevin is intrinsically inactive and cannot interact with syntaxin/SNAP-25 unless a  
membrane-solubilizing detergent is present (Chen et al., 2004; Kweon et al., 2003b). The 
first major goal of this work is therefore to ascertain whether reconstituted synaptobrevin 
is indeed refractory to SNARE complex formation.  
If reconstituted synaptobrevin is able to form a complex, using kinetic traces from 
fluorescence spectroscopy measurements in combination with simulations and fitting of 
the data, I shall ask what the assembly pathway of the SNAREs is on membranes. The 
factors that may affect the kinetics of assembly shall be probed. Intrinsic factors like the 
interfacial residues suggested to cause membrane-insertion of the membrane-proximal 
region and effect of intracellular compoents shall be explored. Among the extraneous 
factors to be investigated shall be temperature, membrane fluidity, lipid composition, 
divalent ions, chaotropicity, electroconductivity and salt composition.  
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Synaptobrevin in synaptic vesicles has also been suggested to be inhibited from 
engaging with syntaxin and SNAP-25 in a complex (Hu et al., 2002; Hu et al., 2004). I 
therefore intend to probe the reactivity of synaptobrevin in native vesicles and compare it 
to that of the reconstituted protein. In view of the report that synaptic vesicles fuse with 
syntaxin/SNAP-25 liposomes only in the presence of micromolar amounts of calcium, I 
ask if SNARE complex assembly on synaptic vesicles is influenced by calcium.  
Synaptobrevin has been shown to be involved in a heterodimeric interaction with 
synaptophysin (Calakos and Scheller, 1994; Edelmann et al., 1995; Washbourne et al., 
1995). This interaction is mutually exclusive to its interaction with syntaxin/SNAP-25 
(Edelmann et al., 1995). A goal of this work is therefore to ask if synaptobrevin must first 
dissociate from synaptophysin to form the SNARE complex or whether the binding of 
syntaxin/SNAP-25 to synaptobrevin disrupts its interaction with synaptophysin.  
 Direct visualization of the SNARE complex within a cell without genetic 
manipulation has not been possible. I therefore intend to raise and characterise in 
immunoblots, cell-lines and plasma-membrane sheets, monoclonal antibodies that would 
recognise only the SNARE complex but not the individual monomers.  
 The next task shall be to determine whether the binding of the antibodies to the 
SNARE complex abolishes its disassembly by NSF/α-SNAP, which could form the basis 
of interesting and meaningful functional assays. I shall endeavour to determine the status 
and dynamics of SNARE complexes within a cell or pre-synaptic nerve-terminal. Among  
the parameters that I intend to investigate are subcellular localization of the complex, 
level of SNARE complexes in a resting cell and whether that level changes when 
stimulated for exocytosis.  Finally, I would determine whether the antibodies can inhibit 
or potentiate release from permeabilized PC-12 cells, which would provide further 
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Acetic acid, Merck (Darmstadt, Germany) 
Acrylamide/Bisacrylamide solution, Roth (Karlsruhe, Germany) 
Adenosine 5´-triphosphate (ATP), Fluka (Switzerland) 
Agarose (low EEO), Applichem (Darmstadt, Germany) 
Albumin, bovine serum, Sigma (Deisenhofen, Germany) 
Ammoniumpersulfate (APS), Sigma (Deisenhofen, Germany) 
Ammonium Chloride, (Nagy et al.) 
Ampicillin, Roth (Karlsruhe, Germany) 
ß-Mercaptoethanol, Sigma (Deisenhofen, Germany) 
BCIP, Boehringer (Mannheim, Germany) 
Bromophenol blue, Sigma (Deisenhofen, Germany) 
Bradford-Reagent, Biorad (Richmond, USA) 
Calcium chloride dihydrate, Fluka (Switzerland) 
Coomassie Brilliant Blue R-250, Serva (Heidelberg, Germany) 
CHAPS, Sigma (Deisenhofen, Germany) 
Cholate 3α7α12αTrihydroxy5βcholan 24oic acid sodium salt, Sigma (Deisenhofen, 
Germany) 
Creatinine Kinase, Roche Diagnostics (Basel, Switzerland) 
Creatinine Phosphate, Roche Diagnostics (Basel, Switzerland) 
D (+)- Glucose, Sigma (Deisenhofen, Germany) 
Dako Fluorescent mounting medium, Dako Diagnostika (Dako, Denmark) 
Dithiothreitol (DTT), Roth (Karlsruhe, Germany) 
Dipotassium hydrogen phosphate, Merck (Darmstadt, Germany)  
Disodium hydrogen phosphate, Merck (Darmstadt, Germany) 
DMF, Merck (Darmstadt, Germany) 
Disuccinimydyl suberate (DSS), Pierce (USA) 
EDTA Titriplex III, Merck (Darmstadt, Germany) 
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EGTA, Sigma (Deisenhofen, Germany) 
Ethanol, Merck (Darmstadt, Germany) 
Glycine, Sigma (Deisenhofen, Germany) 
Hepes-(2-hydroxyethyl)piperazine–N´-2-ethanesulphonicacid),GERBU(Gaiberg, 
Germany) 
Hydrochloric acid, Merck (Darmstadt, Germany) 
Ionomycin, Merck (Darmstadt, Germany) 
Imidazole, Sigma (Deisenhofen, Germany) 
Isopropanol, Merck (Darmstadt, Germany) 
Isopropyl-β-D-thiogalactoside (IPTG), Roth (Karlsruhe, Germany) 
Kanamycin, Roth (Karlsruhe, Germany) 
L-Glutamic acid monopotassium Sigma (Deisenhofen, Germany) 
Magnesium chloride, Sigma-Aldrich (St.Louis, USA) 
Methanol, Merck (Darmstadt, Germany) 
N,N,N',N'- Tetramethylethylendiamine (TEMED), Biorad (Richmond, USA) 
N-Ethylmaleimide (NEM), Sigma (Deisenhofen, Germany)                            
NBT, Boehringer (Mannheim, Germany) 
Nycodenz, Nycomed Pharma  from Axis-Shield Group (Oslo, Norway)                  
Octylglucoside, GERBU(Gaiberg, Germany) 
Paraformaldehyde, Sigma-Aldrich (St.Louis, USA)        
Poly-L-Lysine, Sigma (Deisenhofen, Germany)                                           
Potassium acetate, Merck (Darmstadt, Germany) 
Potassium dihydrogen phosphate, Merck (Darmstadt, Germany) 
Potassium hydroxide, (Nagy et al.) 
Potassium Iodide, (Nagy et al.) 
PMSF (paramethyl sulphonyl fluoride), Roth (Karlsruhe, Germany) 
Protease K, Boehringer (Mannheim, Germany) 
Sodium chloride, Merck (Darmstadt, Germany) 
Sodiumdodecylsulfate (SDS), Biorad (Richmond, USA) 
Sodium hydrogen carbonate, Merck (Darmstadt, Germany) 
Sucrose, Roth (Karslruhe, Germany) 
Tricine, Applichem (Darmstadt, Germany) 
Tris (hydroxymethyl)-aminomethane (Tris), Merck (Darmstadt, Germany) 
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Triton X-100, Merck (Darmstadt, Germany) 
Trypsin, Sigma (Deisenhofen, Germany) 
Urea, Merck (Darmstadt, Germany) 
 
2.1.2 Materials for bacterial culture  
                                                    
Tryptone, Roth (Karlsruhe, Germany)  
Yeast extract, Roth (Karlsruhe, Germany)  
Agar-agar, Roth (Karlsruhe, Germany)  
LB (Luria Bertani) media: 10g tryptone, 5g yeast extract and 5g NaCl, add 1 liter distilled 
water (added 12g agar for solid media)  
TB (Terrific broth) media: 13.3g tryptone, 26.7g yeast extract, 4.4ml glycerol.  








.   
Before inoculation, the media were autoclaved and brought to room temperature. In the 
case of TB media, after autoclaving, TB salt was added.  
 
2.1.3 Bacterial stains  
 
The following strains were obtained from (Stratagene, La Jolla, CA, USA)  
Escherichia coli BL21 (DE3) B F– dcm ompT hsdS (rB– mB–) gal λ (DE3)  
Escherichia coli XL-1-Blue recA1, endA1, gyrA96, thi-, hsdR17, (rk-, mk+), supE44, 
relA1, lac-, [F', traD36, proAB, lacIqZ∆M15, Tn10 (tetr)]  
Escherichia coli JM109 e14–(McrA–) recA1 endA1 gyrA96 thi-1 hsdR17 (rK–mK+) 
supE44 relA1 ∆(lac-proAB) [F´ traD36 proAB lacIqZ∆M15]. 
Escherichia coli M15 strain contained additional pREP4 plasmid. 
 
2.1.4 Enzymes  
 
Restriction endonucleases, New England Biolabs (Ipswich, USA) or MBI Fermentas 
(Ontario, Canada)  
Lyzozyme, Applichem (Darmstadt, Germany)  
DnaseI, Applichem (Darmstadt, Germany)  
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2.1.5 Fluorescent labels  
 
Oregon Green® 488 iodoacetamide, Invitrogen (USA)  
Texas Red® C5 bromoacetamide, Invitrogen (USA)  








Phosphatidylserine sodium salt (brain) 




2.1.7 Instruments  
 
ÄKTA explorer (GE Healthcare) 
Luminescent image analyzer, LAS-1000 Fujifilm (Japan)  
Fluoromax-2, Horiba Jobin Yvon (Edison, NJ, USA)  
Flurolog, Horiba Jobin Yvon (Edison, NJ, USA) 
GeniosPro microplate fluorescence reader (Tecan) 
UV-spectrophotometer, UV-2401 PC Shimadzu (Japan) 
 
2.1.8 Instruments for making Lipid-mix 
Rotavapor R-124, Büchi,  
Vacuum Controller B-720, Büchi,  
Waterbath B-480, Büchi,  
 
2.1.9 Centrifuges  
J6-MI, Beckman (Palo Alto, CA, USA) 
Optima TL X Ultracentrifuge, Beckman (Palo Alto, CA, USA) 
Optima L-90K Ultracentrifuge, Beckman (Palo Alto, CA, USA) 
 
 
Materials and Methods 
 26
 
RC 5C Plus centrifuge, Sorvall (Bad Homburg) 
RC 5B Plus centrifuge, Sorvall (Bad Homburg) 
 
2.1.10 Rotors  
 
SLA-3000, (SuperLiteTM GSA), Sorval, (Bad Homburg) 
SLA-1500, (SuperLiteTM GSA), Sorval, (Bad Homburg) 
SW 28, Beckman (Palo Alto, CA, USA)  
SW41, Beckman (Palo Alto, CA, USA)  
SW50.1, Beckman (Palo Alto, CA, USA)  
SS34, Sorvall, (Bad, Homburg) 
TLA 55, Beckman (Palo Alto, CA, USA) 
TLA 100.3, Beckman (Palo Alto, CA, USA)  
TLA 120.2, Beckman (Palo Alto, CA, USA)  
TLS 55, Beckman (Palo Alto, CA, USA) 
Ti70, Beckman (Palo Alto, CA, USA) 
Ti 50.2, Beckman (Palo Alto, CA, USA)  
 
2.1.11 Gelsystems and power supply 
 
Electrophoresis chamber Mini-Protean II, Biorad (Richmond, USA) 
Geldryer Model 583, Biorad (Richmond, USA) 
Power Pac 200, Biorad (Richmond, USA) 
Power Pac 300, Biorad (Richmond, USA) 
 
2.1.12 Softwares  
 
Aida Image Analyzer, Raytest (Straubenhardt, Germany) 
Corel Graphics suite 11, Corel Corporation 
Endnote 9, Thomson 
Kaleidagraph v4.03, Synergy software 
Matlab 7.1, The MathWorks Inc. (Massachusetts, USA) 
Pro-Kineticist II, Applied Photophysics, (Leatherhead, UK)   
Pymol, DeLano Scientific LLC 
 
 





G25-Sepahadex Beads, Pharmacia Biotech (Freiburg) 
G50-Sephadex Beads, Pharmacia Biotech (Freiburg) 
Gene Pulser II BioRad (Richmond, USA) 
Microcon Centrifugal filter devices (Amicon) 
Molecular weight protein standards, Sigma (Deisenhofen) 
Molecular weight protein standards, MBI Fermentas 
Ni-NTA-Superflow Beads, Qiagen (Hilden) 
Protein-G Sepharose 4FastFlow (GE Healthcare) 
Western Lightning Chemiluminiscence Kit, Perkin Elmer 
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2.2 Methods  
 
2.2.1 Protein Constructs and Molecular Cloning 
 
All recombinant proteins were derived from cDNAs encoding for rat proteins and 
sub-cloned into pET28a, pET30, pET15, pHO2c or pGEX vectors (Novagen, Darmstadt, 
Germany) or pEQ3 (Qiagen, Hilden, Germany) which encode for either an amino-
terminal His6-tag or an N-terminal GST-tag. SNAP-25 (no cysteine), synaptobrevin (aa 1-
96), syntaxin (aa 180-262), SN1 (SNAP-25A aa 1–83), the second helix of SNAP-25a., 
SN2 (SNAP-25A aa 120–206) (Fasshauer et al., 1998a), syntaxin(aa 1-288), syntaxin 
C225, syntaxin C197, SNAP-25 C84, SNAP-25 C130 (Margittai et al., 2001) and full-
length synaptobrevin (aa 1-116) (Margittai et al., 1999),  syntaxin (aa 183-188) (Schuette 
et al., 2004), endobrevin SNARE motif (Fasshauer et al., 1999), syntaxin (aa 183-240), 
synaptobrevin (aa 1-81), synaptobrevin (aa 1-70), synaptobrevin (aa 25-96), 
synaptobrevin (aa 35-96), SNAP-25A, BoNT/A fragment (aa 1–197) (Fasshauer and 
Margittai, 2004), syntaxin (aa 1-262) (Margittai et al., 2003b), tomosyn SNARE-motif 
(Hatsuzawa et al., 2003) SNAP-23 (Wolfram Antonin), synaptobrevin (aa 1-76) 
(Margittai PhD Thesis) have been have been described previously. TeNT, BoNT C and 
BoNT A light chains, encoded in pEQ3 (Qiagen, Hilden) were gifts from H. Niemann 
(Medizinische Hochschule, Hannover, Germay). Cloning was performed according to 
standard protocols (Sambrook, 2001). Enzymes for DNA manipulations were obtained 
from New England Biolabs (Beverly, MA), and Ni-NTA agarose from Qiagen, 
oligonucleotides were obtained from MWG Biotech AG (Ebersberg, Germany). All other 
reagents were purchased from Sigma (Deisenhofen, Germany). Plasmid manipulations 
were performed using the Escherichia coli XL1-Blue strain. Single cysteines in the 
cytsoplasmic regions were introduced at positions 28, 61 and 79 of full-length 
synaptobrevin by site directed mutagenesis (Martin Margittai, unpublished work). 
Tryptophan residues at positions 89 and 90 of full-length synaptobrevin and of its 
respective single cysteine variants were mutagenized to serine residues using the forward 
primer: 5’ GCT CAA GCG CAA ATA CTC GTC GAA AAA GCT CAA GAT GAT G 
3’ and reverse primer:  5’ CAT CAT CTT GAG GTT TTT CGA CGA GTA TTT GCG 
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Syntaxin 2, syntaxin 3, syntaxin 4 and syntaxin 5 SNARE motifs were generated by a 
single PCR reaction. cDNAs encoding for rat syntaxin 2, syntaxin 3, syntaxin 4 and 
syntaxin 5 served as templates. The PCR products were cloned into their target vectors via 
an Nde1/Xho1 cleavage site. The cloned products, vector and primers are listed in 
following table. 
      Construct Vector                                               Primer 
Syx2 (aa 184-263) pHO2c Start: 5´-GGAATTC CAT ATG TCA GAT TCA CAG ATT AC  
Stop:5´- GCGCC CTC GAG TTA TCT GGC CTT GCT CTG G 
Syx3 (aa 183-261) pHO2c Start: 5´-GGAATTC CAT ATG GAC TCC CAG ATT TCC AAG 
Stop:5´- GCGGC CTC GAG CTA TCG AGC CTG ACC CTG 
Syx4 (aa 192-270) pHO2c Start: 5´-GGAATTC CAT ATG GAC ACA CAG GTG ACC CG  
Stop: 5´- GCGCC CTC GAG CTA CCT CGC CTT CTT CTG 
Syx5 (aa 201-279) pGEX Start: 5´-GGAATTC CAT ATG CAG CTT CAG CTC ATT G    
Stop: 5´- GCGCC CTC GAG TCA CCG ATT GGA GGT GAC 
 
2.2.2 Protein Expression and Purification  
 
All proteins, both cysteine free and cysteine containing constructs, were expressed 
in pET28a, pET30, pET15, pHO2c or pGEX vectors (Novagen, Darmstadt, Germany) in 
the BL21(DE3) strain of Escherichia coli containing either ampicillin or kanamycin 
resitance genes. Tetanus toxin light chain and BoNT C light chain, containing both 
kanamycin and ampicillin resistance genes, were encoded in pQE3 (Qiagen) in M15 strain  
of Escherichia coli.  The proteins contained N-terminal His6-tags or GST-tags that were 
utilized to affinity purify them on nickel-nitrilotriacetic acid-agarose (Qiagen, Hilden) or 
sepharose beads coupled to glutathione (Qiagen, Hilden). The N-terminal tags can be 
cleaved off using the protease thrombin.  
Transfection and expression of recombinant proteins were done according to 
(Dower et al., 1988). All plasmids containing the protein constructs were introduced into 
the relevant electro-competent E.coli strain by electroporation in Gene pulser II (Biorad) 
at 1.8 kV, 200 Ω and 25 µF in an electroporation cuvette (diameter 1-2 mm, Biorad). The 
transformed bacteria was plated on Luria Broth (LB) agar plates containing 15% agar and 
either 30 µg/ml kanamycin or 100 µg/ml ampicillin at 37°C for 14h-16h. In the case of 
toxins, both kanamycin and ampicillin were used as antibiotics. 
Bacteria were picked from single colonies and inoculated in 100 ml LB medium 
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incubated overnight at 37°C while shaking. 700 ml TB medium containing 10% TB salt 
or LB medium with the appropriate antibiotic was inoculated with 10 ml of the over-night  
culture and incubated at 37°C while shaking until the absorption at 600 nm reached 0.7-1. 
The protein expression was induced with 1 mM IPTG for 3 to 4 hours. The cultures were 
harvested by cenrtrifugation in 1 litre containers at 4,000 rpm for 15 minutes in the 
Beckman J6-MI centrifuge. The harvested culture was resuspended in extraction buffer 
and incubated with lysozyme, DNAse and PMSF for 15 minutes at RT. Complete lysis 
was done by sonification (4 x 40 pulses, big tip, microtip limit). Bacterial debris was 
removed by centrifugation in an SLA-1500 or SLA-3000 rotor (Sorvall) (30 min at 
16,000 rpm). Ni-beads or GST-Sepharose suspension was incubated with the supernatant 
for 3-4 h at 6°C. After several washes with washing buffer (50 mM Tris/HCl, pH 7.4, 250 
mM NaCl, 4 mM Imidazole) for His-tagged proteins and (20 mM Tris, pH 7.4, 250 mM 
NaCl, 1 mM EDTA, 1 mM DTT) for GST-tagged proteins, protein was eluted with 
elution buffer (50 mM Tris/HCl, pH 7.4, 250 mM NaCl 400 mM Imidazol) for His-tagged 
proteins and (50 mM Tris, pH 7.4, 50 mM Glutathione, 100 mM NaCl, 1 mM EDTA, 1 
mM DTT) for GST-tagged proteins. The tags were cleaved by thrombin (1U/µl) during 
overnight dialysis (20 mM Tris, pH 7.4, 50 mM NaCl, 1 mM DTT) in a dialysis bag of 2-
10 kDa molecular weight cut-off (Spectra Por molecular porous membranes, Spectrum). 
Proteins with transmembrane region were not purified further. Their purity was 
determined by SDS-PAGE. Protein concentration was determined by Bradford test 
(Bradford, 1976) and the proteins were stored at –80°C.  
  Syntaxin (aa 183-288) tended to form inclusion bodies that remained in the pellet 
after centrifugation. After high speed centrifugation (14500 g), the pellet was partially 
resuspended in 200 ml extraction buffer containing 6M Urea, 1.5% sodium cholate and 10 
mM ß-mercaptoethanol, sonicated and incubated at 6oC for 2½ hours. The solution was 
cleared by centrifugation and incubated with Ni-beads followed by the procedures 
decribed above. 
Proteins without transmembrane regions were further purified on a Mono Q (eg. 
syntaxin and SNAP-25) or Mono S column (eg. synaptobrevin) using the Äkta Explorer 
(GE Healthcare). After loading, the proteins were eluted with a linear gradient of NaCl 
(20 mM Tris pH 7.4, 50 mM NaCl, 20 mM, 1 mM DTT and 20 mM Tris pH 7.4, 1 M 
NaCl, 1 mM DTT ). 3 mM (final concentration.) DTT was added to the eluates. The peak 
fractions were pooled and analyzed on SDS-PAGE.  
 
 




2.2.3 Determination of Protein Concentration 
 
Protein concentration was determined according to Bradford (Bradford, 1976). A 
set of standards containing 1, 2, 3, 4, 5 µg bovine serum albumin and the proteins were 
diluted in 200 µl dH2O and then mixed with 800 µl Bradford solution, blanked against a 
similar preparation of Bradford reagent containing no protein. After incubation for 5 min 
at RT the absorbance at 595 nm wavelength was measured using a photometer (Pharmcia 
Biotech Novaspec II). The slope and the intercept as well as the correlation coefficient of 
the standard curve could be determined using the appropriate functions in Microsoft 
Excel. The correlation coefficient of the standard curve was taken as a quality indicator of 
the measurement and was usually greater than 0.995. The measured sample absorbance 
was multiplied with the slope and the product was added to the intercept value of the 
standard curve to obtain the protein concentration of sample. 
 
2.2.4 Protein Labeling with Fluorescent Dyes 
 
Proteins with single cysteines at specific sites were labeled with dyes that react 
with the sulfhydryl group of cysteine. Proteins were first dialysed in degassed buffer 
overnight followed by dialysis for two hours in degassed buffer saturated with N2. The 
fluorescent dyes, Oregon Green 488 iodoacetamide, or Texas Red C5 bromoacetamide  
were dissolved in DMF and incubated for 2h at 6°C in a ten-fold molar excess to the 
proteins to ensure that all sulfhydryl groups of the cysteines conjugated with the dyes.  
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The labelled proteins were applied on Biorad EconoColumn containing G-25 
sephadex beads followed by extensive dialysis (PBS, 20 mM Na2HPO4, pH 7.4, 150 
NaCl) to remove unbound dye. The proteins were run on 15% SDS gels and documented  
with an LAS-1000 reader (Fujifilm) using the appropriate filter sets (HQ470/40x (Cy2) 
Exiter / HQ525/50m (Cy2) Emitter, and   HQ545/30x (Cy3) Exiter / HQ610/75m (Cy3) 
Emitter). All labeled proteins were more than 95% pure and free of unincorporated label. 
Wherever needed, the proteins were concentrated in Microcons (YM-10). 
 
2.2.5 Liposomes reconstitution 
 
Lyophylized lipids (Avanti Polar Lipids) were solubilized in chloroform/methanol 
in a 2:1 (V/v) ratio immediately before use. Phosphatidylcholine, phosphatidyl-
ethanolamine, phosphatidylserine, phosphatidylinositol and cholesterol were mixed in a 
ratio of 5:2:1:1:1 under Argon. Alternatively, for the generation of liposomes with neutral 
lipids, phosphatidylcholine and cholesterol were mixed in a ratio of 7:3 under Argon. A 
third lipid mix of 1-Palmitoy-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC): 1,2-
Dioleoyl-sn-Glycero-3-Pospho-L-Serine (DOPS) in a ratio of 85:15 was prepared under 
argon. The lipid mixtures were dried on a rotary evaporator and resuspended in cholate 
buffer (20 mM Tris pH 7.4, 120 mM NaCl, 1 mM DTT, 5 % cholate (w/v)) at a detergent 
to lipid molar ratio of 8:1 and a final lipid concentration of 13.5 mM.  Protein and the 
lipid-micellar mix containing 5% cholate were mixed in a molar ratio of 1:100 with the 
volume of the lipid micellar mix being 100 µl. If the concentration of the protein was 
considerably low, it was concentrated in the Centricon MWCO 10.000. The protein-lipid 
mix was incubated at 4oC for 30 min followed by size exclusion chromatography on 
Biorad Econo Column of 0.7 cm diameter and 15 cm length packed with Sephadex G-50 
(superfine) equilibrated in PBS or Hepes-buffered K-Glut (20 mM Hepes-KOH, pH 7.2, 
120 mM potassium glutamate, 20 mM potassium acetate and 1mM EDTA). For the 
removal of unincorporated proteins, 500 µl of the liposome fraction was mixed with an 
equal volume of 80% Nycodenz in buffer, overlaid with 500 µl of 30% Nycodenz and 150 
µl of buffer. The gradient was centrifuged at 165,000 g for 4 h in Beckman Ultra Clear 11 
x 34 mm centrifuge in TLS 55 rotor. Liposomes were retrieved from the top of the 
gradient. A typical preparation yields 300 µl of liposome containing buffer. To determine 
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population. The liposomes were frozen in liquid nitrogen and stored at –80°C. 
Occasionally, the integrity and size of the liposomes was checked for by electron 
microscopy. The proteoliposomes containing the neuronal SNAREs had a diameter 
between 30 nm to 50 nm. The preparations were analyzed on 15% SDS-PAGE. 
 
2.2.6 Digestion of proteoliposomes with toxins to determine protein orientation 
 
Tetanus toxin and Botulinum C are clostridial neurotoxins, the light chains of 
which are highly selective SNARE proteases. Whereas Tetanus toxin light chain 
selectively cleaves synaptobrevin between residues 76 and 77 (Eisel et al., 1986; 
Fairweather et al., 1986), Botulinum C cleaves syntaxin between residues 253 and 254 
(Hauser et al., 1990). The toxins cleave only if the SNAREs are surface exposed in 
reconstituted liposomes. This was used as a tool to determine the orientation of 
synaptobrevin or syntaxin incorporated in liposomes. Synaptobrevin liposomes were 
incubated with Tetanus toxin light chain and syntaxin liposomes were incubated with 
BoNT C light chain at 37oC for 1-2 h in the presence or absence of 1% CHAPS. 
Reactions were stopped by SDS containing sample buffer. The samples were analyzed on 
15% SDS-PAGE followed by Coomassie staining or were documented with an LAS-1000 
reader (Fujifilm) using the appropriate filter sets (HQ470/40x (Cy2) Exiter / HQ525/50m 
(Cy2) Emitter, and   HQ545/30x (Cy3) Exiter / HQ610/75m (Cy3) Emitter). 
 
2.2.7 Preparation of synaptic vesicles from rat brain 
 
Synaptic vesicles were purified from rat brains as described in detail in previous 
publications (Hell, 1994; Huttner et al., 1983; Nagy et al., 1976). All materials and 
reagents were kept detergent free to avoid disruption of the vesicles. The entire prep was 
carried out at 4°C. 20 whole rat brains were homogenized in Hepes-buffered at pH 7.2 
0.32 M sucrose using a glass/teflon homogenizer (9 strokes at 900 rpm). PMSF and 
pepstatin A were added immediately (to a final concentration of 0.001% V/v using a 200 
mM stock solution). Centrifugation was carried out in Sorvall SS-34 rotor for 10 min at 
800 x g (2700 rpm). The supernatant (S1) was again centrifuged in SS-34 rotor for 15 min 
at 9200 x g (10 000 rpm). The pellet (P2) was resuspended in 120 ml 0.32 M sucrose and 
centrifuged in the SS-34 rotor for 15 min at 9200 x g (11 000 rpm). The resuspended 
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M Hepes-buffered sucrose. The crude synaptosomal fraction was subjected to osmotic 
lysis by adding nine volumes of distilled water to the resuspended pellet and homogenized  
in a glass/teflon homogenizer (3 strokes at 2000 rpm). 1.2 ml of Hepes-NaOH pH 7.2 and 
PMSF were added. The lysate was centrifuged in the SS-34 rotor for 20 min at 25,000 x g 
(16,500 rpm). The supernatant (LS1) was removed and spun in a Beckmann ultra-
centrifuge Ti 70-rotor for 2 h at 165000 x g (50000 rpm). The pellet (LP2) was 
resuspended and homogenized in 6 ml of 40 mM sucrose, 3 strokes at 3000 rpm in glass 
teflon homogenizer. Subsequently, the homogenate was taken in with a 20G needle and 
pressed through a 27G needle. This crude synaptic vesicle fraction was loaded on top of a 
continuous sucrose gradient (top: 50 mM sucrose; bottom: 800 mM sucrose) and 
centrifuged in a SW 28-rotor for 4 h at 65,000 x g (23000 rpm). The vesicle-containing 
band was pumped out of the gradient (approximately at 200-400 mM sucrose). This 
fraction was loaded on top of the controlled pore glass bead column and eluted over night 
in buffered glycine (5 mM Hepes-KOH, pH 7.3, 300 mM glycine). The flow rate was 
adjusted to approximately 40 ml/h. The absorbance at 280 nm wave-length was recorded 
and fraction sizes of 5-6 ml were collected. Vesicle containing fractions were pooled (the 
second peak of the UV-recording corresponds to the synaptic vesicles) and spun in an 
ultracentrifuge, Ti 50.2-rotor for 2 h at 165,000 x g (50000 rpm). The pellet was 
resuspended in 0.5 ml Hepes buffered at pH 7.2 K-Glut solution, taken in with a 20G 
needle and pressed through a 27G needle. Protein concentration of the vesicles was  
determined by Bradford assay as described above. Occasionally, the integrity and size of 
the vesicles was checked for by electron microscopy. 50µl aliquots of purified synaptic 
vesicles were shock frozen in liquid nitrogen and stored at -80° C.  
2.2.8 Preparing and running  SDS-PAGE gels (Laemmli, 1970) 
 
For SDS-PAGE gels the following components were mixed for the stacking and 
the separation gels (15%). Ready-to-use gas stabilized solutions of 30% acrylamide and 
0.8% bisacrylamide were used to prepare the gels. 
            Composition of 15% SDS-PAGE gel: 
Component Stacking gel (3.75%) 
(4 gels) 
Separation gel (15%) 
(2 gels) 
Acrylamide 30% 1.25 ml 5.0 ml 
Gel buffer 2.5 ml 2.5  ml 
H2O 6.14 ml 2.4 ml 
TEMED 10 µl 5 µl 
10 % APS 100 µl 100 µl 
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 The glass walls, spacers (0.75 mm) and the combs were cleaned with ethanol and 
mounted in the holder. 3.4 ml of the separation gel were poured between the glass walls.  
This was overlayed with iso-butanol saturated with water to smoothen the interface 
between the stacking gel and the separation gel. After the polymerization of the separation 
gel, the iso-butanol was removed and the remaining volume was filled with stacking gel 
and the comb was inserted. After the gel had polymerized, the protein samples were 
mixed with the SDS loading buffer, either 2x or 5x sample buffer, and loaded either 
directly or boiled for 5 min before loading on the gel. The gel chamber was filled with 
running buffer. The proteins were loaded into the pockets of the gel and electrocuted at 
constant current of 15 mA. After the blue front reached the separation gel boarder the 
current level was elevated to 25 mA. The gel was allowed to run till the blue front 
diffused out of the gel. (Upper gel buffer: 0.5 M Tris(HCl, pH 6.8, 0.4% SDS, Lower gel 




After electrophoresis, the stacking gel was discarded and the separation gel was 
stained for 15-30 min in 50% (V/v) methanol, 10% (V/v) acetic acid and 0.2% (W/v) 
Coomassie Brilliant Blue R-250 while shaking. The gel was destained in 50% (V/v) 
ethanol and 10% (V/v) acetic acid for 15 min and then in 10% (V/v) ethanol and 5% (V/v) 
acetic acid until no background was left. The gels were scanned, dried in the gel dryer 




Gels were blotted in a semi-dry transfer mode (Towbin et al., 1989) using 
nitrocellulose membranes (GB003 from Schleicher & Schuell). Per membrane a current 
of 50 mA was applied for 50 minutes. The membrane was subsequently blocked by 
incubation in 5% low fat milk solution for at least 30 minutes followed by incubation for 
at least 60 min at RT with the primary antibody at a 1:1000 or 1:2000 dilution in 5% low 
fat milk solution. After three washing steps in wash buffer (0.2 M TrisHCl pH 7.8, 0.1% 
Tween-20 (V/v), 0.15M NaCl,) for at least 5 minutes each, horseradish peroxidase (HRP) 
or alkaline phosphatase (AP) conjugated secondary antibody was added (dilution 1:1000 
to 1:2000) in 5% low fat milk solution and incubated for 30 minutes. Again, three  
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washing steps were performed before enhanced chemiluminiscence reagent (for HRP-
conjugated secondary antibody) was applied according to manufacturer’s instruction 
(Perkin Elmer Western Lightning) and detected using the luminescent image analyzer  
(LAS-1000 Fujifilm). For AP- conjugated secondary antibody, a combination of nitro 
blue tetrazolium (0.33 mg/ml) and 5-bromo-4-chloro-3-indolyl phosphate (0.17 mg/ml) 




Immunoprecipitation was done essentially as described in (Edelmann et al., 1995). 
Lysate pellet 2 (LP2, pre-incubated or not with soluble syntaxin and SNAP-25 for 1.5 h) 
or P2’ (crude synaptosomal fraction) was dissolved in ice-cold extraction buffer (20 mM 
Hepes-KOH pH 7.3, 140 mM KCl, 2 mM EDTA,1-1.5% Triton X-100 or 1% CHAPS). 
Protein amount was adjusted to 1 to 1.5 mg/ml, and the insoluble material was removed 
by centrifugation for 30 min at 100,000 x g. 7.5 µl of ascites fluid corresponding to ~8-25 
µg specific IgG per ml solution were added and incubation was carried out for 8-10 h at 
4oC. 75 µl of protein G- Sepharose suspension (GE Healthcare) /ml of detergent extract 
was incubated for 1-1.5 h. The beads were collected by centrifugation and washed three 
times in extraction buffer before elution with sample buffer containing SDS and ß-
mercaptoethanol. 
 
2.2.12 Cross-linking  
 
Cross-linking was done as described in (Edelmann et al., 1995). For cross-linking, 
LP2 was resuspended at a protein concentration of 1 to 1.5 mg/ml in Krebs-Ringer buffer 
(1.2 mM Na2HPO4, 5 mM NaHCO3, 140 mM NaCl, 1 mM MgCl2,) and pre-warmed for 
10 min at room temperature. Disuccinimidyl suberate (DSS) was dissolved in DMSO at a 
final concentration of 5 mM. Crosslinking was carried out at RT for 45 min. The reaction 
was quenched with Tris-Cl, pH 7.4, (100 mM final concentraion) for 30 min at RT. The 
membranes were pelleted in a microfuge at 5000 rpm for 3 min and then resuspended in 1 
ml ice-cold buffer (20 mM Tris-Cl pH 7.4, 150 mM NaCl) containing 1% Triton X-100 
and incubated at 4oC for 1 h. Insoluble material was removed by centrifugation at 40 000 
rpm (100,000 g) for 20 min in TLA 55 rotor. 20 µl aliquots of the supernatants were 
analyzed by SDS-PAGE followed by immunoblotting.  
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2.2.13 In vitro formation of SNARE complexes 
 
Binary and ternary complexes used in the Coomassie staining and immunoblotting 
studies were formed overnight (unless otherwise stated) in the stoichiometric ratios stated 
in the figure legends. Complex formation was verified by nondenaturing PAGE (binary 
complexes) or SDS-PAGE (ternary complexes). Some of the complexes were purified by 
anion-exchange chromatography (MonoQ, GE Healthcare).  
 
2.2.14 Tetanus toxin protection assay 
 
Tetanus toxin cleaves synaptobrevin 2 specifically between glutamine 76 and 
phenylalanine 77. When synaptobrevin is in the complex, tetanus toxin cannot cleave it. 
Protection of synaptobrevin from cleavage is an indication of the cleavage site being 
occluded in a complex. SNARE complex was generated as described above. 
Subsequently, the volume was filled up to 50µl with K-Glut buffer (120 mM potassium 
glutamate, 20 mM potassium acetate, 20 mM Hepes, pH 7.2) and 1µl of recombinantly 
expressed tetanus toxin light chain was added (corresponding to 1.2 µg of protein and a 
final concentration of approximately 500 nM). Equal amount of proteoliposomes of the 
same preparation alone served as control. The solutions were incubated for 1h at 37° C 
before SDS-PAGE.  
 
2.2.15 Absorption Spectroscopy  
 
The labeling efficiencies were determined from the absorption spectra, according 
to the Beer-Lambert law.  
 
The extinction coefficients were used as given by the provider (ε (Oregon Green) 
490nm = 70000 M-1cm-1, (ε (Texas Red)590 = 80000 M-1cm-1)). All measurements 
were carried out in a Shimadzu (UV-2401 PC) spectrophotometer. (Ax represents 
Absorption) 
 
2.2.16 Fluorescence Anisotropy 
 
All measurements were carried out in a Fluoromax-2 (Horiba Jobin Yvon) with 
automated polarizers (Model: 1971) or Fluorolog-3 (Horiba Jobin Yvon) with in-built  
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polarizers essentially as described in (Fasshauer and Margittai, 2004). Excitation and 
emission wavelengths were 488 nm and 520 nm, respectively (Oregon green). The slit 
widths were set between 2.5 nm and 3.5 nm to ensure fluorescence intensities between 
80,000 and 100,000 cps. The integration time was set at 1 sec. The G-factor was 
determined according to G = IHV/IHH, where IHV and IHH are the fluorescence intensities of 
the vertically and horizontally polarized emissions when the sample is excited with 
horizontally polarized light. After measuring the intensities of the vertically and 
horizontally polarized emissions upon vertically polarized excitation (IVV and IVH, 
respectively), the anisotropy values were computed automatically by the software 
according to following relationship: r = (IVV-GIVH)/(IVV+2GIVH) (Lakowicz, 2000). The 
concentration of the labeled protein was always kept between 70 nM and 300 nM. To start 
SNARE assembly, the unlabeled reactants were always added in large excess to saturate 
the reaction. The temperature was kept constant at 25°C throughout the experiment. All 
assembly reactions were carried out in quartz cuvettes (Hellma) in a final volume of 2.5 
ml.  
 
2.2.17 Förster Resonance Energy Transfer (FRET) 
 
Förster resonance energy tranfer (FRET) experiments were carried out in 
Fluoromax-2 spectrometer (Horiba Jobin Yvon) or Fluorolog-3 (Horiba Jobin Yvon) as 
described in (Fasshauer and Margittai, 2004). All measurements were carried out at 25oC 
(37oC for disassembly) in 1-cm quartz cuvettes (Hellma) in PBS (unless otherwise stated). 
FRET measurements were done by donor excitation at 488 nm and monitoring donor 
(OG) fluorescence emission (520 nm) and acceptor (TR) fluorescence emission (610 nm). 
The slit widths were set to 1-4 nm and the integration time was set to 1s. Spectra were 
measured before and after the reaction. The change in fluorescence intensity over time 
was observed for both the donor and the acceptor molecules. All assembly and 
disassembly reactions were carried out in quartz cuvettes (Hellma) in a final volume of 
2.5 ml and 2 ml respectively.  
FRET was also monitored in 96-well plates in a total volume of 100 µl in 
GeniosPro (Tecan) using excitation filter of 490 nm and and emission filters of 510 nm 
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2.2.18 Kinetic Simulations 
 
Simulations were performed on the complete 4D data matrix (time, wavelength, 
fluorescence, concentration) with the specialized 4D data fitting software Pro-Kineticist II 
(Applied Photophysics, UK), a second order global and local analysis software. For 
fitting, the residuals and the resulting sum of squares were calculated by Newton-Raphson 
algorithm and numerical integration. Subsequent iterations were performed using the 
derivative of the residuals matrix and shifts in the rate and formation constants. Kon and 
Koff were determined in the global analysis mode for reaction intermediates and products 
by the simultaneous analysis of multiple datasets gathered at different sets of initial 
conditions. 
 
2.2.19 Antibody binding to ternary complex on synaptic vesicles 
 
Soluble syntaxin (4.7 nmoles) and SNAP-25 (3.43 nmoles) were incubated with 
purified synaptic vesicles (117 µg) overnight. 20 µl of ascites cleared by centrifugation at 
100,000 x g for 15 min in TLA 120.2 rotor was incubated with synaptic vesicles +/- 
syntaxin/SNAP-25. The mixes were pelleted at 100,000 x g for 15 min in TLA 120.2 
rotor. After three washes in PBS, the pellets were resuspended in 50 µl of the same buffer, 
5 µl of which was analyzed in SDS-PAGE followed by Coomassie staining. 
 
2.2.20 Extraction of rat brain cytosol 
 
Cytosol was prepared from the brains of freshly killed male adult Wistar rats 
(Klenchin et al., 1998). The brain stem and cerebellum were not used. Brains were placed 
into isotonic solution (50 mM PIPES, pH 6.8, 130 mM NaCl, 2 mM EGTA, 1 protease 
inhibitor cocktail tablet, Boehringer Mannheim, Germany; 1 ml/brain) and homogenised 
with 1 slow and 3 fast strokes of a Teflon homogeniser running at 900-1000 rpm at 4°C. 
Larger debris was removed by centrifugation at 14500 g in SS-34 rotor for 15 minutes at 
4°C. The supernatant was collected and centrifuged at 128000 g (rotor TLA 100.3, 
Beckman) for 60 min at 4°C in order to remove mitochondria and myelin. The second 
supernatant was dialysed against 4 l of ice-cold K-Glut buffer for 2 h, with a change of 
buffer every half an hour. Cytosol was aliquoted, frozen in liquid nitrogen and stored at –
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2.2.21 [3H]-NE release assay from PC-12 cells 
 
Streptolysin-O based PC-12 cells release assay was adapted from Klenchin et al. 
(Klenchin et al., 1998). PC-12 cells were cultured in uncoated 6-well plates in [3H] NE 
(7µCi/15cm diameter plate, stock 40 Ci/mmol, Amersham Biosciences) containing 
medium for 9-12 h. Medium was removed and fresh medium not containing the radiolabel 
was added to the culture for the ‘chase’ period. Cells were subsequently placed on ice and  
washed with PBS and PBS/0.2% BSA followed by incubation with Streptolysin-O (75 
µg/ml, final concentration) for 10 min on ice. After another wash with PBS to remove 
excess Streptolysin-O, cells were incubated for 12 min at 37oC in permeabilisation buffer 
(20 mM Hepes, pH7.2, 120 mM KCl, 20 mM K-Acetate, 4 mM MgCl2) in the presence or 
absence of antibodies in 0.1% BSA. For stimulation, Ca+2 (10 µM final conc.), Rat brain 
cytosol (2 mg/ml, final concentration), EGTA (5 mM, final concentration), ATP (2 mM, 
final concentration), Creatine phosphate (CP, 26 mM, final concentration) and Creatine 
Kinsae (CK, 0.132 mg (800 units/mg) Roche, Basel, Switzerland) were added to the 
permeabilisation buffer. For negative control, calcium, ATP, CP, CK and rat brain cytosol 
were omitted. Stimulation was done for 25 min at 37oC with 0.1% BSA. Supernatants 
were removed and pellets were solubilized in Triton X-100. Activity was measured in a 
liquid scintillation counter. 
 
2.2.22 Cell culture 
 
Experiments were performed using the neuroendocrine cell line PC-12 clone 251 
(Heumann et al., 1983). PC-12 cells were cultured in 75 cm2 uncoated flasks in DMEM 
with 4.5 g/l glucose supplemented with 10% fetal calf serum (FCS), 5% horse serum, 4 
mM L-glutamine and 60 U/ml each of penicillin and streptomycin at 37°C in 10% CO2. 
For splitting or plating on coverslips, cells were washed with PBS and detached with 3 ml 
trypsin-EDTA (Bio-Whittaker Europe, Verviers, Belgium) for 1 min. Trypsin activity was 
quenched by addition of 15 ml growth medium and the cells were centrifuged at 235 g at 
20°C for 5 min. The pellet was titurated in growth medium. Aliquots of approximately 2 x 
105 cells were seeded on 25 mm coverslips coated with poly-L-lysine. After additional 15 
minutes to allow the cells to settle, 2.5 ml of growth medium was added. Cells were used 
for the experiments at least 24 h after. 
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2.2.23 Preparation of active synaptosomes 
 
Synaptosomes were prepared from adult (250 grams) rats. Four rats were 
decapitated, the brains were removed into ice-cold sucrose buffer (5 mM Hepes, pH 7.4, 
320 mM sucrose,). The cortex and cerebellum were homogenized in 90 ml of sucrose 
buffer (10 strokes at 900 rpm, in presence of protease inhibitors, 0.2 mM PMSF and 1 
µg/ml of pepstatin A). Cellular fragments were pelleted by centrifugation at 2000g (2 
minutes) in a Sorvall SS34 rotor. The supernatant was centrifuged further at 9500g for 12 
minutes, rendering a pellet consisting mainly of synaptosomes, mitochondria and myelin. 
The pellets were resuspended (avoiding the relatively harder mitochondrial component) in 
10 ml sodium buffer (20 mM Hepes pH 7.4, 140 mM NaCl, 5 mM KCl, 10 mM glucose, 
5 mM NaHCO3, 1.2 mM Na2HPO4, 1 mM MgCl2) and centrifuged at 9500g. They were 
then resuspended in 1-2 ml sodium buffer and used within 1 hour for release experiments. 
 
2.2.24 Synaptosome stimulation 
 
Synaptosomes were pre-incubated at 37ºC for 20 minutes. Ca2+ (1.3 mM) or 5 mM 
EGTA were added for a further 10 minutes. Stimulation was then performed for 5-7 
minutes by addition of 50 mM KCl or 10 µM ionomycin, followed by placing the 
synaptosome-containing tubes on ice and immediate disruption by hypo-osmotic shock 
(addition of a 9-fold higher volume of ice-cold water, and homogenization using a glass 
teflon homogenizer, six strokes at maximum speed). The plasma membranes and 
smaller vesicles were pelleted separately by differential centrifugation (see section on 




Immunocytochemistry was done essentially as described in (Willig et al., 2006). 
PC-12 cell cultures were fixed for 30-45 minutes with 4% paraformaldehyde, quenched 
with 50 mM ammonium chloride (in PBS) for 15 minutes, permeabilized with 0.1% 
Triton X 100, and incubated for 1 hour with primary antibodies diluted at 1:100 in 
PBS/1% BSA/0.1% Triton X 100. The coverslips were then washed three times with 
PBS/0.1% Triton X-100, and secondary antibodies were added for one hour. The cultures 
were then washed with high salt PBS (three times, 500 mM NaCl in 20 mM sodium 
phosphate buffer, pH 7.4), low salt PBS (150 mM NaCl in 10 mM sodium phosphate  
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buffer, pH 7.4) and PBS, mounted in Dako mounting medium (DakoCytomation) and 
imaged. 
 
2.2.26 Fluorescence microscopy 
 
A Zeiss Axiovert 200M fluorescence microscope was used, equipped with a 1.4 
NA 100x objective and a CCD camera with a 1317 x 1035 Kodak chip 
(pixel size 6.8 x 6.8 µm, Princeton Instruments Inc., USA). Cy3 fluorescence (red 
channel) was detected using the excitation filter 565/30X-HQ, the beamsplitter 595 
DCLP-Q, and the emission filter 645/45M-HQ. Cy2 fluorescence was detected with the 
excitation filter 480/40X-HQ, the beamsplitter 505 DCLP-HQ, and the emission filter 
527/30M-HQ. 
 
2.2.27 Direct labeling of synaptic vesicles 
 
Highly enriched synaptosomes were obtained by Ficoll gradient centrifugation 
(Nicholls and Sihra, 1986), and synaptic vesicles were generated (LS1). They were then 
labeled and processed as published previously (Brandhorst et al., 2006). Imaging and data 
analysis was performed as previously described (Brandhorst et al., 2006). Experiments 




Twenty bands were cut out from a lane of 15% SDS-PAGE in which the 
immunoprecipitate had been run. Proteins were digested with trypsin and peptides were 
extracted from the gel. Extracted peptides were subjected to nano LC-coupled 
Electrospray Ionization (ESI) tandem mass spectrometry. Proteins were identified by 
searching the fragment pattern of the sequenced peptides against the NCBInr database 
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2.2.29 Generation, immuonostaining, image acquisition and data analysis of 
membrane sheets 
 
Experiments with plasma membrane sheets were done as described in (Lang et al., 
2002). Membrane sheets were generated from cells grown on poly-L-lysine-coated 
coverslips by using a 100-ms ultrasound pulse in ice-cold K-Glut buffer (20 mM Hepes, 
pH 7.2, 120 mM K-Glutamate, 20 mM K-Acetate, 10 mM EGTA). The membrane sheets 
were either directly fixed in 4% paraformaldehyde (PFA) or incubated in a humid 
chamber with synaptobrevin (aa 1-96) labelled at position 28 with Alexa594 (4µM or 10  
µM) at 37°C in K-Glut buffer containing 3%BSA for 30-60 min. Membrane sheets were 
then washed with PBS (10 mM NaH2PO4, pH 7.4, 10 mM Na2HPO4, 150 mM NaCl) two 
times for 10 min each at RT followed by fixing for 30 min at RT with 4% PFA dissolved 
in PBS.  PFA was quenched for 20 min in PBS containing 50 mM NH4Cl. Incubation 
with primary antibody (1-2 h, 1:100 dilution ) and following washing steps (2x 10 min. 
each) were carried out in PBS (+/- 1% BSA and +/- 500 mM NaCl  as indicated). 
Incubation with secondary antibody (1-2 h, goat-anti–rabbit-Cy2, 1:200 dilution) was 
carried out in PBS. Membrane sheets were then washed three times in PBS for 10 min, 
and imaged in 4% 1-(4-trimethylammonium)-6-phenyl-1,3,5-hexatriene (TMA-DPH)–
saturated PBS solution . In some experiments fluorescent beads (tetraspeck beads) were 
used as a spatial reference.       
 Fluorescence microscopy and quantification of immunofluorescence intensity was 
performed essentially as previously described (Lang et al., 2002). For correlation analysis, 
regions of a size of several µm2 were extracted from both channels using the program 
Metamorph (Universal Imaging corporation, West Chester, PA, USA) and imported in the 
program Sigma Plot (Systat Software, Inc., Richmond, USA). The Pearson Corrleation 
coefficient was calculated according to r = Σi(greeni-greenav)*(redi-redav)/{Σi(greeni-
greenav)2*Σi(redi-redav)2}1/2 (Manders et al., 1992). For each experiment comparing 135.1  
staining with syb 2-Alexa594 labeling, 5-14 individual membrane sheets (on average 10) 
were analysed, and three experiments were performed. The mean ± S.E.M. are given. One 
experiment was performed comparing 69.1 staining with syb 2-Alexa594 labeling, 









3.1 SNARE complex assembles on artificial vesicles 
 
 Studies probing the reactivity and the assembly pathway of neuronal SNAREs, the 
putative fusogens, are essential to the understanding of factors that govern neuro- 
exocytosis. Cytoplasmic domains of neuronal SNAREs are known to spontaneously 
assemble into a tight ternary complex. This complex is resistant to SDS treatment and 
migrates in SDS-PAGE without dissociating into its monomers, thus indicating SNARE 
complex formation (Hayashi et al., 1994). SNARE complexes dissociate into their 
individual components upon heating (Fig. 4). Extensive studies have enhanced 
understanding of the assembly pathway of soluble domains of SNAREs, reviewed in 
(Fasshauer, 2003). It was proposed that the soluble domain of synaptobrevin readily binds 
to the syntaxin/SNAP-25 acceptor complex (Fasshauer and Margittai, 2004). The 
reactivity of synaptobrevin reconstituted in liposomes, however, has been called into 
question. It was proposed that synaptobrevin in membranes is refractory to SNARE 
complex formation, thus requiring additional factors for activation (Hu et al., 2002; 
Kweon et al., 2003b). These studies imply that SNAREs are incapable of interacting with 
each other in their native environment, unless an activating factor, probably a Ca+2 sensor, 
relieves the inhibition of synaptobrevin. A major goal of this work, therefore, was to 
examine the reactivity of membrane-anchored synaptobrevin.  
 
Figure 4. SNARE complex formation using soluble domains of SNAREs, monitored by SDS-
PAGE and Coomassie Blue staining.  
Incubation of syntaxin 1, SNAP-25 and synaptobrevin (aa 1-96, Syb) in the stoichiometric ratio of 
2 (SNAP-25): 1 (syntaxin): 1 (synaptobrevin) results in the appearance of SDS-resistant bands of 
higher molecular mass (Ternary complex). The SDS-resistant bands dissociate into their 







3.1.1 Liposomes do not influence assembly of soluble domains of SNAREs 
 
The proposed inhibition of synaptobrevin could be traced to its interaction with 
the membrane. This inhibition may arise from the interaction of its interfacial residues (aa 
77-90) with membrane, as this domain has been shown to bind to membranes (Quetglas et 
al., 2000).  Alternatively, the trans-membrane region could confer structural features 
rendering it incapable of contacting its binding partners. To test the former possibility, 
i.e., whether the assembly of soluble domains of SNAREs is influenced by lipids, SNARE 
complex formation was monitored by Förster resonance energy transfer (FRET) in the 
presence or absence of protein free liposomes. Versions of synaptobrevin (aa 1-96) and 
SNAP-25 (full-length) in which single cysteines were introduced at positions 28 and 130 
respectively were purified and labelled with Oregon Green (OG) as donor (Syb28OG) and 
Texas Red (TR) as acceptor fluorophore (SNAP-25130TR), respectively. The rate of 
SNARE complex assembly, reported by donor fluorescence quenching, does not change 
significantly when approximately 100 µM protein-free liposomes was included in the 
reaction (Fig. 5), suggesting that the assembly of SNAREs without intact trans-membrane 
regions is independent of their interaction with the lipids. 
 
Figure 5. SNARE complex formation of soluble synaptobrevin (aa 1-96), syntaxin (aa 180-262) 
and SNAP-25 in the presence or absence of protein free liposomes. 
Complex formation was monitored by FRET (donor quenching). Synaptobrevin, labeled 
at position 28 with Oregon Green (Syb28OG, final conc ~ 200 nM.) was incubated with 
SNAP-25 labeled at position 130 with Texas Red (SNAP-25130TR, final conc. ~300 nM). 






formation. Note that the presence of protein free liposomes did not alter the rate of 
complex formation of soluble SNAREs. Insert: cartoon of SNARE complex crystal 
structure indicating the labeling positions (black spheres). 
 
3.1.2 SNARE complex assembles on syntaxin proteoliposomes 
 
In the next set of experiments I asked whether syntaxin inserted in liposomes is 
active and readily engages in SNARE complexes with its cognate SNAREs. To test 
whether membrane-bound syntaxin is sufficient to interact with synaptobrevin and SNAP-
25, the trans-membrane domain containing syntaxin with either only the SNARE motif 
(aa 180-288) or full-length (aa 1-288) were reconstituted into liposomes. Liposomes were 
generated from cholate extracts using size-exclusion chromatography and further purified 
on Nycodenz density gradients. Syntaxin-containing liposomes were incubated with 
soluble synaptobrevin and SNAP-25 for 6 h at room temperature (RT). As shown in Fig. 
6, both versions of syntaxin in liposomes engage soluble synaptobrevin and SNAP-25 to 
form SNARE complexes that are detectable as SDS-resistant bands of higher molecular 
weight.   
 
 
Figure 6. SNARE complex formation on syntaxin (Syx-) liposomes monitored by SDS-PAGE 
followed fluorescence detection or Coomassie staining. 
a) SNARE complex formation on syntaxin (aa 180-288) liposomes monitored by SDS-
PAGE followed by detection of fluorescence derived from synaptobrevin. Incubation of 
syntaxin liposomes (120 pmoles) with SNAP-25 (500 pmoles) and soluble synaptobrevin 
(aa 1-96) labeled at position 28 with Oregon green (Syb28OG, 250 pmoles) results in the 
appearance of SDS-resistant bands of higher molecular mass (Ternary complex). The 
reaction was carried out in a total volume of 50 µl for 6h and was stopped by adding 50µl 
2x sample buffer containing SDS; 5 µl of this reaction was analyzed. 
b) SNARE complex formation on full length syntaxin (aa 1-288) liposomes monitored by 
SDS-PAGE and Coomassie staining. Syntaxin full-length liposomes (Syx FL PL, 30 
pmoles) was incubated with SNAP-25 (50 pmoles) and soluble synaptobrevin (aa 1-81, 50 
pmoles). A band of higher molecular mass (Ternary complex) was visible which 







3.1.3 SNARE complex assembles on synaptobrevin proteoliposomes 
 
The results described above indicate that syntaxin inserted in liposomes can 
engage soluble synaptobrevin and SNAP-25 in SNARE complexes. Does synaptobrevin 
reconstituted in liposomes form SNARE complex with the soluble domain of syntaxin 
and SNAP-25? Several reports suggest that membrane-inserted synaptobrevin is largely 
inactive (Hu et al., 2002; Hu et al., 2003; Kweon et al., 2003b): when isolated synaptic 
vesicles were incubated with recombinant SNAP-25 and syntaxin 1, no complex 
formation was observed (Kweon et al., 2003b). Furthermore, when recombinant 
synaptobrevin incorporated in liposomes was incubated with syntaxin and SNAP-25, 
complexes were not detected unless membrane-solubilizing detergent was added 
suggesting that synaptobrevin is intrinsically inactive when inserted into a bilayer (Kweon 
et al., 2003b). To test these findings and further resolve the issue of SNARE complex 
assembly on synaptobrevin liposomes, purified synaptobrevin was incorporated into 
liposomes in a manner similar to what has been described for syntaxin above. 
Reconstitution results in random orientation with nearly 50% of the protein pointing out 
of the lumen of the liposomes, as seen by the cleavage of synaptobrevin by the light chain 
of Tetanus toxin (TeNT) (Fig. 7). When the liposomes were treated with TeNT in the 
presence of membrane solubilizing detergent, the entire pool of synaptobrevin was 




















Figure 7. Orientation of synaptobrevin reconstituted in liposomes. 
Synaptobrevin proteoliposomes were incubated with Tetanus toxin light chain (TeNT)  in the 
absence or presence of membrane-solubilizing detergent (2% CHAPS) and analyzed on an SDS-
PAGE followed by Coomassie Blue staining.  Full-length synaptobrevin was completely cleaved 
by TeNT resulting in a fragment of synaptobrevin (aa 1-76) indicating that the protease was 
active. Almost 50% of synaptobrevin inserted in liposomes was cleaved by TeNT suggesting 
random orientation. When synaptobrevin proteoliposomes were treated with TeNT in the presence 
of detergent, the cleavage was complete. 
 
To investigate whether the correctly oriented synaptobrevin in liposomes is 
capable of forming SNARE complexes, recombinant SNAP-25 (full-length) and syntaxin 
were incubated with synaptobrevin liposomes in a stoichimetric ratio of 2 
(synaptobrevin): 1 (SNAP-25): 1 (syntaxin). As shown in Fig. 8a, SNARE complexes 
formed that are detectable as SDS-resistant bands. The remaining synaptobrevin was 
resistant to toxin cleavage indicating that the entire pool of surface exposed synaptobrevin 
was recruited into SNARE complexes. Heating dissociated the complexes into their 
monomers (Fig. 8), as is usual for SNARE complexes. 
 
Figure 8. SNARE complex formation on synaptobrevin (Syb)-containing liposomes, monitored 
by SDS-PAGE and Coomassie Blue staining. 
a) Addition of syntaxin 1 (aa 180-262, Syx) and SNAP-25 results in the appearance of SDS-
resistant bands of higher molecular mass (Ternary complex). Treatment of liposomes with 







synaptobrevin by about 50% (left lanes). After SNARE complex formation, the remaining 
synaptobrevin was resistant to toxin cleavage (right lanes), suggesting that this pool is 
oriented towards the vesicle interior. About 300 pmoles of synaptobrevin in liposomes 
was incubated with 150 pmoles of SNAP-25 and of syntaxin overnight. 
b) The SDS-resistant bands dissociate into their monomeric constituents when the sample is 
boiled prior to SDS-PAGE. Assembly was carried out as in a). 
 
3.1.4 Fluorescence spectroscopy assays report kinetics of SNARE complex 
formation on artificial vesicles 
 
As a measure of kinetics of SNARE complex assembly, complex formation was 
monitored by fluorescence anisotropy using single cysteine mutants of synaptobrevin 
labelled with the fluorophore Oregon Green (Syb28OG, Syb79OG, Syb61OG) incorporated in 
liposomes. To validate that the fluorescent labels on synaptobrevin did not sterically 
hinder SNARE complex formation, it was incubated with recombinant SNAP-25 and 
syntaxin in the same stoichiometric ratio as described for Fig. 8. As shown in Fig. 9a, 
SDS-resistant bands of higher molecular weight representing the ternary complex formed, 
documenting that the fluorophores do not prevent complex formation. Anisotropy 
represents the rotational motion of a fluorophore during its excited-state lifetime, thereby 
reporting local conformational flexibility of the dye that increases upon increasing 
constraints on the fluorophore. An increase of anisotropy, denoting complex formation, 
was observed for all labelling positions of synaptobrevin in liposomes upon addition of 
unlabelled syntaxin and SNAP-25 (Fig. 9), which was prevented in the presence of 























Figure 9.  SNARE complex formation on synaptobrevin (Syb)-containing liposomes monitored     
by SDS-PAGE and fluorescence anisotropy. 
a) SNARE complex formation with fluorescently labeled synaptobrevin monitored by SDS-
PAGE and Coomassie Blue staining to show that the fluorescent label does not hinder its 
capacity of engaging syntaxin and SNAP-25 in a complex. Synaptobrevin labeled at 
positions  28 or 79 with Oregon Green (Syb28OG  and Syb79OG  respectively) incorporated 
in liposomes were incubated with syntaxin and SNAP-25 essentially as described in Fig. 
8. SDS-resistant bands of higher molecular mass (ternary complex) appeared which 
dissociated into their monomers upon boling. 
b) c) and d) Complex formation monitored by fluorescence anisotropy, using Syb61OG (b) , 
Syb79OG (c) and Syb28OG  (d) containing liposomes (all ~100 nM). Anisotropy increased 
when unlabeled soluble syntaxin (1.25 µM) and SNAP-25 (1.92 µM) were added to the 
reaction. Excess soluble synaptobrevin (5 µM) blocks the increase in anisotropy. Cartoons 
indicate the labeling position (black spheres) on synaptobrevin in liposome in the crystal 
structure of the SNARE complex.   
 
To characterize SNARE complex assembly on membranes in more detail, FRET 
was used to report complex formation. Single cysteine mutants of each of the SNAREs 
was purified and labelled with either Oregon Green (OG) as donor (Syb28OG, Syb79OG, 
Syb61OG) or Texas Red (TR) as acceptor (SNAP-25130TR, SNAP-2584TR, Syx225TR, 
Syx197TR). FRET was monitored between the fluorophores on synaptobrevin and SNAP-
25 or between the fluorophores on synaptobrevin and syntaxin. In the crystal structure of 
the SNARE complex, all FRET pair positions are adjacent to each other on the outside of 
the complex, thus allowing to monitor complex formation while not interfering with the 
binding sites. As shown in Fig. 10a, FRET between Syb28OG containing liposomes and 
SNAP-25130TR results in altered emission spectra upon donor excitation maxima at 488 
nm before and after SNARE complex formation. Upon incubation with detergent 
(CHAPS, final conc.1%) for 1h, further signal change was observed, in agreement with 
the finding that a fraction of synaptobrevin is oriented into the lumen of liposomes. FRET 
between Syb79OG containing liposomes and SNAP-2584 TR was observed when unlabelled 
syntaxin was added to the reaction. Donor fluorescence decreased (upper panel, Fig. 10b) 







Figure 10. SNARE complex formation on synaptobrevin (Syb)-containing liposomes,   monitored 
by FRET between synaptobrevin and SNAP-25                                        
a) FRET between Syb28OG containing liposomes and SNAP-25130 TR. Emission spectrum (λex 
488 nm, donor λem 520 nm and acceptor λem 610 nm) was recorded before and after 
incubation of Syb28OG reconstituted in liposomes (125 nM), SNAP-25130 TR (~300 nM) and 
syntaxin (1.25 µM) for ~1h. Upon incubation with detergent (CHAPS, final conc.1%) for 
1h, further increase in FRET was observed indicating that a fraction of synaptobrevin was 
oriented in the lumen of liposomes. 
b)  FRET between Syb79OG containing liposomes and SNAP-25 labeled at postion 84 with 
Texas Red (SNAP-2584 TR).  Syb79OG in liposomes (~600 nM) was incubated with 
unlabeled syntaxin (1.25 µM). Upon addition of SNAP-2584 TR (~1.1 µM), donor 
fluorescence decreased (upper panel) while acceptor fluorescence increased (lower panel), 
indicating complex formation. Cartoons indicate labeling positions on synaptobrevin in 








SNARE complex assembly on membranes was further validated by FRET pairs 
between synaptobrevin and syntaxin. FRET between Syb61OG and Syx225TR (Fig. 11a) and 
Syb28OG and Syx197TR (Fig 11b) was observed upon addition of SNAP-25. Again, soluble 
unlabeled synaptobrevin effectively competed with the labeled synaptobrevin for complex 
formation. Furthermore, FRET was abolished when synaptobrevin liposomes were pre-
incubated with trypsin (Fig. 11c), further documenting that the signal change observed 







Figure 11.  SNARE complex formation on synaptobrevin (Syb)-containing liposomes, monitored 
by FRET between synaptobrevin and syntaxin                                          
a) and c) FRET between Syb61OG and syntaxin labeled at position 225 with Texas Red 
(Syx225TR). Syb61OG, reconstituted in liposomes (~ 100 nM final conc.) were incubated 
with Syx225TR (final conc. ~300 nM). Upon addition of SNAP-25 (1.28 µM (a), 2 µM (c)) 
donor fluorescence decreased, indicating complex formation. Addition of soluble 
unlabeled synaptobrevin (a) (2.5 µM final conc.) effectively competed with the labeled 
synaptobrevin for complex formation. FRET was not observed when synaptobrevin 
liposomes was preincubated with 1 mM trypsin for 2h and quenched with PMSF prior to 
the reaction(c) 
b) FRET between Syb28OG and syntaxin labeled at position 197 with Texas Red (Syx197TR). 
Syb28OG, reconstituted in liposomes (~ 125 nM final conc.) was incubated with Syx197TR 
(final conc. ~370 nM). Upon addition of SNAP-25 (1.28 µM final conc.) donor 
fluorescence decreased, indicating complex formation. Addition of soluble unlabeled 
synaptobrevin (~2.5 µM final conc.) effectively competed with the labeled synaptobrevin 
for complex formation.  




3.1.5 Reconstituted synaptobrevin engages SNAP-25 and syntaxin with the intact 
N-terminal domain in a complex 
 
The results described above show that synaptobrevin in liposomes is fully 
available for SNARE complex assembly with SNAP-25 and the SNARE motif of 
syntaxin. The N-terminal region of syntaxin, known as the Habc domain, however, has 
been reported to have an inhibitory effect on SNARE complex formation (Margittai et al., 
2003c). To determine whether synaptobrevin in liposomes is capable of engaging SNAP-
25 and syntaxin with the intact N-terminal domain (syntaxin aa 1-262) in a complex, 
equimolar amount of all three proteins were mixed. As shown in Fig. 12a, SDS-resistant 
ternary complex was visible, which dissociated into its components upon heating. SNARE 
complex formation was also monitored by FRET. Synaptobrevin, labeled at position 61 
with Texas Red was reconstituted in liposomes and incubated with syntaxin (aa 1-262) 
labeled at position 225 with Oregon Green. Upon addition of SNAP-25, FRET occurred, 
indicating complex formation (Fig. 12b). It is notable that the rate of complex formation 
with syntaxin (aa 1-262) is considerably slower than that with only the SNARE motif, as 










Figure 12. SNARE complex formation on synaptobrevin (Syb)-containing liposomes with      
SNAP-25 and syntaxin (aa 1-262), i.e., syntaxin with the N-terminal Habc domain intact.  
a) SNARE complex formation was monitored by SDS-PAGE and Coomassie Blue staining. 
Addition of entire cytoplasmic domain of syntaxin 1 (aa 1-262) and SNAP-25 results in 
the appearance of SDS-resistant bands of higher molecular mass (Ternary complex). 
Incubation with SNAP-25 and syntaxin (aa 1-262) was carried out overnight (all proteins 
being 50 pmoles). The SDS-resistant bands dissociate into their monomeric constituents 
when the sample is boiled prior to SDS-PAGE.  
b) SNARE complex formation was monitored by FRET (donor quenching). Synaptobrevin, 
labeled at position 61 with Texas Red was reconstituted in liposomes (~ 150 nM final 
conc.) and incubated with syntaxin (aa 1-262) labeled at position 225 with Oregon Green 
(final conc. ~100 nM). Upon addition of SNAP-25 (~1.92 µM), donor fluorescence 
decreased indicating complex formation. For comparison, ternary complex formation 
using Syx 180-262 (see legend to Fig. 11) is shown (gray line). 
 
 
3.1.6 Synaptobrevin in aged or frequently frozen/thawed liposomes becomes 
refractory to SNARE complex assembly 
 
The results described so far demostrate clearly that SNARE complex assembles on 
synaptobrevin liposomes. It was noted, however, that synaptobrevin in liposomes 
becomes refractory to SNARE complex assembly after prolonged storage (>10 days on 
ice) or frequent freeze-thaw cycles (>3 times). As shown in Fig. 13a, complex formation 
on freshly prepared liposomes resulted in a shift of synaptobrevin to an SDS-resistant 
band of higher molecular weight whereas on aged liposomes, synaptobrevin did not enter 
SNARE complex. Treatment of freshly prepared liposomes with the light chain of tetanus 
toxin (TeNT) before addition of SNAP-25 and syntaxin cleaved nearly half of 
synaptobrevin corresponding to its random orientation in liposomes whereas 
synaptobrevin in aged liposomes was resistant to toxin cleavage (Fig. 13a). Using the 






quenching was greatly retarded for synaptobrevin in aged liposomes. Results from 
electron microscopic analysis of liposomes (not shown) suggest that liposomes aggregate 
after prolonged storage. Together, these results indicate that though synaptobrevin in 
liposomes is fully available for complex formation, aged and frequently frozen and 
thawed liposomes tend to cluster and aggregate, thus rendering the synaptobrevin 
incorporated in them unavailable for complex formation. 
 
Figure 13. Synaptobrevin in liposomes becomes refractory to SNARE complex assembly after 
prolonged storage or frequent freeze-thaw cycles. 
a) SNARE complex formation on synaptobrevin liposomes (Antonin et al.), monitored by SDS-
PAGE and immunoblotting for synaptobrevin. Syntaxin (40 pmoles) and SNAP-25 (100 
pmoles) were incubated with synaptobrevin liposome (old and fresh, 80 pmoles) for 4h in 50 
µl volume. The reactions were stopped by adding 50µl 2x sample buffer containing SDS; 5 µl 
of the reactions were analyzed.  
b) SNARE complex assembly monitored by FRET (Syb61OG/Syx225TR ) as described in Fig. 11a. 
 
3.2 Kinetics of SNARE complex assembly on artificial vesicles 
 
The FRET assays described above enable the monitoring of the assembly of 
SNAREs on membranes. Likewise, the effects of extraneous and endogenous factors on 
SNARE complex assembly rate can be monitored. These studies could lead to a clearer 
understanding of the factors and conditions determining SNARE complex assembly on 
membranes. In view of the reports that reconstituted synaptobrevin is in an“off-state”,  
unless membrane-solubilizng detergent is included (Hu et al., 2002; Kweon et al., 2003b), 
it is notable that in the present study, the rate of complex assembly increased only 







that synaptobrevin in liposomes is not significantly retarded from forming SNARE 
complexes. 
 
Figure 14. SNARE complex formation on synaptobrevin (Syb)-containing liposomes in the    
presence of detergent proceeds only moderately faster. 
SNARE complex formation was monitored by FRET (Syb61OG/Syx225TR) (see legend to Fig. 11a) 
except that the the reaction carried out in the presence of detergent was in 1% CHAPS. 
Concentration of SNAP-25 was ~1.92 µM. 
 
3.2.1 Assembly of SNARE complex on membranes proceeds via the  syntaxin/ 
SNAP-25 binary complex 
       
It was shown earlier that a 1:1 complex between syntaxin and SNAP-25 is 
required for binding of synaptobrevin and that syntaxin competes with synaptobrevin for 
this binding, resulting in the formation of a non-productive 2:1 complex between syntaxin 
and SNAP-25 (Fasshauer et al., 2002; Fasshauer and Margittai, 2004). Excess of SNAP-
25 shifts the equilibrium to the 1:1 acceptor complex, which is expected to result in an 
enhanced rate of ternary complex formation. In my study, the FRET assay was used to 
investigate whether the rate of complex formation is dependent on the concentration of  
SNAP-25. Two different FRET pairs (Syb61OG and Syx225TR) (Fig. 15a) and (Syb28OG and 
Syx197TR) (Fig 15c) reported an increase in the rate of complex formation with increasing 
concentration of SNAP-25. No complex formation was observed in the absence of SNAP-
25 (Fig. 15a).  Preincubation of syntaxin and SNAP-25 leads to a higher concentration of 
syntaxin/SNAP-25 acceptor complex, offsetting any time-delay for its formation. 






complex formation than if all components were added sequentially, thereby precluding 
any delayed formation of the acceptor complex. As shown in Figs. 15b and 15d, this was  
indeed the case: preincubated reactions were significantly faster than when all 








Figure 15. Increasing concentrations of SNAP-25 profoundly accelerates the rate of complex 
formation. 








a) and c) Increasing amounts of SNAP-25 shifted the equilibrium towards the 1:1 
syntaxin/SNAP-25 acceptor complex, yielding higher concentration of binding sites for 
synaptobrevin thereby resulting in faster rate of SNARE complex formation 
b) and d) Pre-mixing of  syntaxin and SNAP-25 (FRET pair Syb61OG/ Syx225TR final conc. 
250 nM and 1.28 µM respectively and FRET pair Syb28OG/Syx197TR final conc. 125 nM 
and 1.92 µM respectively) results in a faster onset of complex formation indicating that 
the formation of acceptor complexes between syntaxin and SNAP-25 is initially rate-
limiting. 
 
3.2.2 Kinetic Modelling of SNARE complex assembly on membranes 
 
The SNAP-25 titration experiments enables one to model the reaction pathway 
and determine Kon and Koff of reaction intermediates. The SNAP-25 titration experiments 
were used to simulate the reaction scheme described in Fig. 16b. Applying the Newton-
Raphson algorithm and numerical integration in an iterative process for minimization of 
residuals (Peduzzi et al., 1979), the simulated traces were fitted to the experimental ones 
(Fig. 16a, 17a and 18a). The goodness of the fit can be judged from the residuals that 














Figure 16.  Simulation followed by fitting of the kinetic traces obtained in the SNAP-25 titration  
experiment, (FRET between Syb61OG/Syx225TR). 
(experimental traces were the ones shown in figure 15a). The simulations and fitting were done 
essentially as described in the Methods. Note that whereas the kon and koff for the syntaxin/SNAP-
25 1:1 acceptor complex remains the same as was determined for the soluble proteins (ref), the 
binding of synaptobrevin to the acceptor complex was retarded.  
a) Plots of experimental traces with the fitted data. Red trace represents experimental trace, 
black trace represents fitted trace. 
b) Kinetic model that was used for simulation and the kon and koff of reaction intermediates 
and product obtained from the fitting represented in the model as k+1, k-1, k+2, k-2 and 
k+3. 
c) Representative trace of residuals for the condition in which the concentration of SNAP-25 
was 2.56 µM. Notice that the residuals trace fluctuates randomly around zero 
d) The sum squares of residuals plotted against the number of iterations.  
 
  The determination of two sets of reaction rates was possible, depending on the 
starting values assigned to the formation and reaction rate constants before the iterative 
process was initiated. In the first fitting regime, using experimental data from titrations of 
SNAP-25 with the FRET pair Syb61OG and Syx225TR, the kon and koff for the 1:1 complex 
between syntaxin and SNAP-25 were calculated to be approximately 1900 M-1s-1 and 
0.0007 s-1 respectively. The Kon for the 2:1 complex between syntaxin and SNAP-25 was 
calculated to be 250 M-1s-1 whereas that of binding of synaptobrevin in liposomes to the 
1:1 syntaxin/SNAP-25 acceptor complex was approximately 4800 M-1s-1 (Fig. 16b). In 
this solution, it is noteworthy that the formation of the ternary SNARE complex is 
favoured over the unproductive 2:1 complex between syntaxin and SNAP-25 by a factor 
of 20. The concentration profiles of the reaction intermediate species suggests that the 1:1 
syntaxin/SNAP-25 accceptor complex is present in large excess over the 2:1 syntaxin/ 
SNAP-25 intermediate (not shown). An important conclusion of this solution was that the 
binding of synaptobrevin to the syntaxin/SNAP-25 complex is very slow (4800 M-1s-1). 
This solution may be flawed since the experimentally determined values of Kon and koff 











Figure 17. Simulation followed by fitting of the kinetic traces obtained in the SNAP-25 titration 
experiment (FRET between Syb61OG/Syx225TR). 
(experimental traces were the ones shown in figure 15a). The simulations and fitting were done 
essentially as described in the Methods. Note that whereas the kon for the syntaxin/SNAP-25 1:1 
acceptor complex remains the same as was determined for the soluble proteins (ref), koff for this 
complex was about 100 times higher than that determined for the soluble proteins. Notice that the 
binding of synaptobrevin to the acceptor complex was rapid.  
a) Plots of experimental traces with the fitted data. Red trace represents experimental data, 
black trace represents fitted data. 
b) Kinetic model that was used for simulation and the kon and koff of reaction intermediates 
and product obtained from the fitting represented in the model as k+1, k-1, k+2, k-2 and 
k+3. 
c) Representative trace of residuals for the condition in which the concentration of SNAP-25 
was 2.56 µM. Notice that though the goodness of the fit was within the error margin, the 
residuals were not uniformly spaced around zero, particularly at the tail end of the fit. 















Figure 18. Simulation followed by fitting of the kinetic traces obtained in the SNAP-25 titration 
experiment (FRET between Syb28OG/Syx197TR). 
(experimental traces were the ones shown in figure 15c). (see legend to figure 17 for details). 
Notice that the residuals trace fluctuates randomly around zero (c). 
 
In the second solution, experimental data from titrations of SNAP-25 with two 
FRET pairs was used. The simulated traces from the fitting of data using the FRET pair 
Syb61OG and Syx225TR result in 7700M-1s-1 and 1s-1 for kon and koff respectively for the 1:1 
complex between syntaxin and SNAP-25. The kon and Koff for the binding of second 
syntaxin molecule to the 1:1 syntaxin/SNAP-25 acceptor complex were 4.94 x 105 M-1s-1 
and 0.00079 s-1 respectively, whereas the kon for the binding of synaptobrevin in 
liposomes to the 1:1 syntaxin/SNAP-25 acceptor complex was 2.21 x 105 M-1s-1 (Fig. 
17b). The rates calculated for the experimental data using the FRET pair Syb28OG and 
Syx197TR were 1260 M-1s-1 and 0.99s-1, 2.75 x 105 M-1s-1, 0.0024 s-1 and 1.79 x 106 M-1s-1 
for k+1, k-1, k+2, k-2 and k+3 respectively (Fig. 18b). Two essential outcomes of the analysis 
using the second solution were that the syntaxin/SNAP-25 1:1 complex on membranes is 
highly unstable and the binding of synaptobrevin to the 1:1 syntaxin/SNAP-25 complex is 
extremely rapid.          
 Thus, two solutions of reaction rates for the intermediates and product were 
arrived at. The first solution suggested that the formation and dissociation of 
syntaxin/SNAP-25 1:1 acceptor is similar to that of the published values for soluble 
SNAREs (Fasshauer and Margittai, 2004). The syntaxin2/SNAP-25 binary complex was, 
however, strongly suppressed during the reaction. Finally, the binding of synaptobrevin to 
syntaxin/SNAP-25 was considerably slow. The second solution indicated that the Kon for 
syntaxin/SNAP-25 and syntaxin2/SNAP-25 were comparable to that of the soluble 
proteins. The binding rate of synaptobrevin to the syntaxin/SNAP-25 acceptor complex, 
however, was rapid (on the order of 105 to 106 M-1s-1). The overall slow rate was traced to 
the high Koff for syntaxin/SNAP-25 complex (about 100 times faster than that estimated 










3.2.3 Substitution of membrane-proximal tryptophan residues by serine does not 
enhance the rate of complex formation 
   
The two highly conserved tryptophan residues at the C-terminal end of the 
SNARE motif of synaptobrevin were reported to cause membrane–insertion of the 
linker connecting the SNARE motif and the transmembrane domain (Kweon et al., 
2003a; Kweon et al., 2003b). These authors reported that synaptobrevin reconstituted in 
liposomes entered into complexes only when the tryptophan residues are replaced with 
serines (Kweon et al., 2003b). The possibility that these tryptophan residues, by causing 
insertion into the lipid bilayer of the membrane-proximal stretch of synaptobrevin (aa 
85-92) compromises its reactivity can be ruled out since the results above show that 
wild-type synaptobrevin in liposomes is fully capable of binding to syntaxin and SNAP-
25. It is possible though that when the proposed membrane-block is relieved by 
replacing the membrane-proximal tryptophan residues with smaller polar residues like 
serine, the rate of complex formation can be significantly enhanced. To assess this 
possibility, synaptobrevin W89S W90S was generated and reconstituted into 
proteoliposomes. Addition of soluble syntaxin and SNAP-25 led to the formation of 
SDS resistant ternary complex that dissociated into its components upon heating (Fig. 
19a), suggesting that the mutant version of synaptobrevin is capable of engaging in 
SNARE complexes. Complex formation was also monitored by fluorescence anisotropy 
as described above. When soluble syntaxin and SNAP-25 were added to synaptobrevin 
W89S,W90S61OG reconstituted in liposomes, fluorescence anisotropy increased, 
denoting complex formation, which was effectively blocked by soluble unlabelled 
synaptobrevin (Fig. 19b). Complex formation rate was monitored in more detail by 
FRET using the FRET pair Syb61OG and Syx225TR. As shown in Fig. 19c, the rate of 
complex formation was not accelerated with respect to the wild-type protein. Similar 
results were obtained when other labeling positions were used (not shown). The rate of 
complex formation increased when the SNAP-25 concentration was increased, as was 
shown for wild-type synaptobrevin (Fig. 19d), suggesting that the assembly pathway of 







Figure 19. Substitution of the membrane proximal tryptophans 89 and 90 with serine does not 
alter the efficiency of synaptobrevin to enter SNARE complexes. 
a) Complex formation, monitored by the appearance of heat-resistant bands after SDS-
PAGE and Coomassie Blue staining. Liposomes were reconstituted with either mutant or 
wild-type synaptobrevin (incubations as in Fig. 8, with approx. 100 and 200 pmoles of 
syntaxin and SNAP-25 respectively). Note that the complex containing synaptobrevin 
W89S W90S migrates somewhat faster in SDS-PAGE, probably indicating a difference in 
the amount of bound SDS. 
b) Complex formation monitored by fluorescence anisotropy. Anisotropy increased when 
unlabeled soluble syntaxin (1.3 µM) and SNAP-25 (2.85 µM) were added to the reaction 
containing Syb61OG W89S, W90S in liposomes (150 nM).  Note that excess soluble 
synaptobrevin (5 µM) blocks the increase in anisotropy 
c) Complex formation, monitored by FRET using the FRET pair Syb61OG/Syx225TR (see 
legend to Figure 11a). Upon addition of SNAP-25 (~1 µM), complex formation on 
liposomes containing either variant of synaptobrevin proceeded at similar rates indicating 
that the mutation of membrane proximal tryptophans to serines does not accelerate the 
reaction rate. 
d)  Increasing concentrations of SNAP-25 profoundly accelerates the rate of complex 
formation indicating that Syb W89S, W90S in liposomes binds to the syntaxin/SNAP-25 








3.2.4 SNARE complex assembly rate is enhanced in the presence of weak 
counterions 
 
The rate of SNARE complex assembly on reconstituted synaptobrevin liposomes 
is very slow when compared to that of soluble SNAREs. It is conceivable that SNARE 
complex assembly on membranes is affected by intracellular factors. To test the 
possibility that intracellular factors may enhance complex assembly rate, the reaction was 
monitored by the FRET assay discussed above in the presence or absence of rat brain 
cytosol. No difference in assembly rate was observed (Fig. 20a). To preclude the 
possibility that the complex that formed was simultaneously disassembled by the NSF/α-
SNAP machinery, NEM, a known inhibitor of NSF and ATPγS, the non-hydrolyzable 
form of ATP that binds to the ATP-binding site of NSF, were included in the reaction. 
The complex assembly rate did not differ from the control reaction suggesting that brain 
cytosolic proteins may not directly catalyze SNARE complex assembly (Fig. 20b). 
 
Figure 20. Rate of SNARE complex formation on synaptobrevin-containing liposomes is not 
changed by brain cytosolic proteins. 
Complex formation was monitored by FRET (see legend to Figure 11a for details).  
a) When Rat Brain Cytosol was added to the reaction cuvette to a final concentration of 1 
mg/ml, complex formation was not enhanced.  
b) To rule out the possibility that NSF/α-SNAP were disassembling the SNARE complexes 
formed, NEM (300 µM final conc.) and ATPγS (400 µM final conc.) were included in the 








The crystal structure of the SNARE complex suggests two divalent co-ordinating 
sites in the groove between SNAP-25 and synaptobrevin (Sutton et al., 1998). The 
presence of calcium in the reaction may thus play a role in complex assembly rate. As 
shown in Fig. 21, using the fluorescence anisotropy assay described above, SNARE 
complex assembly rate was unaffected in the presence of 1 mM calcium.  
The lipid environment in a physiological setting may be different from the reduced 
system used in this study. Furthermore, a study suggested that SNAREs normally prefer 
liquid-disordered phase in the membrane (Bacia et al., 2004). The fluidity of the lipid 
bilayer could thus influence the rate of SNARE complex assembly. The fluidity of a 
bilayer being dependent on temperature (Canvin and Buhr, 1989), SNARE complex 
assembly was carried out at varying temperatures (18oC, 25oC and 30oC).  The rate of 
complex formation, however, remained unchanged, suggesting that the fluidity of 
membrane may have little or no bearing on the rate of assembly of SNAREs (Fig. 21).  
The membrane-proximal region of synaptobrevin (aa 77-90) has been reported to 
bind to liposomes containing acidic phospholipids but not to liposomes containing only 
non-charged phospholipids (Quetglas et al., 2000). This finding raises the possibility that 
binding of syntaxin/SNAP-25 to synaptobrevin reconstituted in liposomes containing only 
neutral lipids might influence the latter’s reactivity. However, in fluorescence anisotropy 
experiments to report complex formation, SNARE complex formation rate with 








Figure 21. Rate of SNARE complex assembly does not depend on extraneous conditions. 
SNARE complex assembly was monitored by fluorescence anisotropy. Upon addition of SNAP-
25 (1.92 µM) to syntaxin (1.25 µM) and  Syb28OG in liposomes (125 nM ), an increase in 
anisotropy was observed. Complex formation rate did not alter if the temperature was raised to 
30oC or lowered to 18oC. When Syb28OG was reconstituted in liposomes composed of neutral lipids 
(phospatidycholine/cholesterol in a ratio of 70:30) or divalent ions (Ca+2, final conc. 1 mM), 
complex formation rate was not altered, indicating that SNARE complex formation is robust and 
relatively independent of exogenous factors.  
 
 
Figure 22. SNARE complex formation on synaptobrevin (Syb)-containing liposomes with a lipid 
content of POPC:DOPS in a ratio of  85:15 , monitored by FRET. 
a) FRET between Syb61OG  and Syx225TR. Syb61OG, reconstituted in liposomes (POPC:DOPS 
in a ratio of 85:15 ) (~ 100 nM final conc.) was incubated with Syx225TR (final conc. ~300 
nM). Upon addition of SNAP-25 (1.92 µM) donor fluorescence decreased, indicating 
complex formation. To test the specificity of signal change, the proteoliposomes were 







b) Increasing concentration of SNAP-25 increased the rate of complex formation (see legend 
to Fig. 15), indicating SNARE complex assembly pathway remains unchanged when 
synaptobrevin is inserted in liposomes of different lipid compositions. 
 
Kweon et al. did not observe SNARE complex assembly on membranes in studies 
using Electron paramagnetic resonance (Kweon et al., 2003b). The lipid composition of 
the liposomes used in their study was POPC:DOPS in a ratio of 85:15. To rule out the 
possibility that SNARE complexes do not form on liposomes composed of POPC/DOPS, 
proteoliposomes containing Syb61OG were generated. When reconstituted synaptobrevin 
was incubated with soluble syntaxin and SNAP-25, SNARE complexes formed, as 
assessed by FRET (Fig. 22). When the proteoliposomes were pre-treated with trypsin, 
complex formation was blocked. As described above, the ternary complex transits through 
the 1:1 acceptor complex between syntaxin and SNAP-25. As per the model, excess of 
SNAP-25 enhances the rate of assembly on synaptobrevin in POPC/DOPS liposomes 
(Fig. 22), indicating that the ability of synaptobrevin incorporated in liposomes of 
different lipid compositions to engage soluble syntaxin and SNAP-25 in a complex is the 
same. Therefore, divalent ions, membrane fluidity, lipid composition and intracellular 
factors do not appear to enhance or mitigate the rate of SNARE complex assembly. Is 
SNARE complex assembly then dependent on extraneous physical parameters like 
chaotropicity, ionic strength or the presence of weak counter-ions? To investigate these 
possibilities, SNARE complex assembly under different solution compositions was 
monitored by the FRET assay. When the salt in the solution was changed from 150 mM 
NaCl to 140 mM KCl or 140 mM KI, no difference in the reaction rate was discernible, 
whereas the absence of ionic charges greatly retarded the reaction rate (Fig. 23a). When 
140 mM K-Glutamate/20 mM K-Acetate was used as the salts in the solution, the reaction 
rate was significantly enhanced (Fig. 23a). Complex formation of soluble SNAREs too 
was monitored  in the presence of 150 mM NaCl or 140 mM K-Glutamate/20 mM K-
Acetate (Fig. 23b). The rate of complex assembly was higher in the K-Glutamate/K-
Acetate solution indicating that the presence of weak counterions at the concentrations 
specified was the sole criteria for the enhancement of SNARE complex assembly rate, a 
condition known to stabilize protein-protein interaction in general (Griep and McHenry, 






Figure 23. Rate of SNARE complex assembly on synaptobrevin-containing liposomes in the  
presence of different solvents. 
(monitored by FRET between Syb61OG/ Syx225TR as described in Fig. 11a except that the 
concentration of SNAP-25 was 1.92 µM) 
a) SNARE complex assembly rate in the presence of KCl, NaCl and KI was unaltered. It 
was retarded in the presence of sucrose and enhanced in the presence of K-Glut/K-
Acetate, indicating that whereas the presence of weak counterions is sufficient to enhance 
the rate of complex formation, the absence of ions can abolish assembly. 
b) SNARE complex assembly rate of souble Syb61OG (150 nM) Syx225TR (500 nM) and 
SNAP-25 (1.28 µM) in presence of 150 mM NaCl or 140 mM K-Glut/20 mM K-Acetate, 
indicating that the even the soluble proteins form SNARE complexes faster in the 
presence of weak counter-ions. 
 
3.3 SNARE complex assembly on synaptic vesicles 
 
The results described so far show that synaptobrevin retains its ability to form 
SNARE complexes after insertion into liposomes. It is possible, however, that in its native 
environment, the reactivity of synaptobrevin is downregulated by interaction with other 
proteins. I therefore investigated whether synaptobrevin in synaptic vesicles can also 
engage in SNARE complexes. In synaptic vesicles purified from rat brains, almost the 
entire pool of synaptobrevin is sensitive to digestion by tetanus toxin light chain (Fig. 24a, 
left), indicating its total outward orientation. Addition of SNAP-25 and syntaxin 
quantitatively shifted the synaptobrevin into an SDS-resistant band of higher molecular 
weight, which, as expected for SNARE core complexes, was insensitive to toxin digestion 
(Fig. 24a, right). Similar results were obtained when the soluble domain of syntaxin with 
the intact N-terminal domain was used instead of the syntaxin with only the SNARE 






As an independent indicator of SNARE complex assembly on synaptic vesicles, 
the FRET assay was used. Since synaptobrevin in the vesicle cannot be selectively 
labelled with a fluorescent dye, an indirect approach was employed to monitor ternary 
SNARE complex. The off-pathway during the assembly of ternary SNARE complex is 
the formation of the syntaxin2:SNAP-25 binary complex. The t1/2 for the dissociation of 
the second syntaxin molecule was determined to be between 400 and 1400 seconds in the 
models discussed above (see Figs. 17 and 18), leading to the transitory syntaxin/SNAP-25 
acceptor complex to which a synaptobrevin molecule can readily bind. The formation of 
the ternary complex is essentially an irreversible reaction. Hence, the addition of 
synaptobrevin to the syntaxin2:SNAP-25 reaction would result in the irreversible 
replacement of one of the syntaxin molecules and provide a ready binding site for 
synaptobrevin. The syntaxin2:SNAP-25 complex was generated by  incubating equimolar 
amounts of SNAP-25 and syntaxin labelled at position 225 with either Oregon Green or 
Texas Red. Since the two syntaxin and the lone SNAP-25 molecule have a parallel 
arragment (Margittai et al., 2001; Xiao et al., 2001), the two syntaxin molecules were 
therefore in a state in which the donor fluorescence was quenched. Increasing amounts of 
synaptic vesicles caused faster irreversible formation of ternary complex, as assessed by 
donor de-quenching (Fig. 24c) or acceptor fluorescence increase (Fig. 24d). These 
experiments lend support to the conclusion that synaptobrevin resident on synaptic 




















Figure 24. SNARE complex assembly on synaptic vesicles (SV). 
a) SNARE complex formation on synaptic vesicles, monitored by SDS-PAGE followed by 
immunoblotting for synaptobrevin. Syntaxin (40 pmoles) and SNAP-25 (100 pmoles) 
were incubated with 5.6 µg of purified synaptic vesicles for 4h in 50 µl volume. The 
reactions were stopped by 50µl 2x sample buffer containing SDS; 5 µl of this reaction 
was analyzed. Complex formation on synaptic vesicles resulted in an almost complete 
shift of synaptobrevin to an SDS-resistant band of higher molecular weight (Ternary 
complex). Treatment of vesicles with the light chain of tetanus toxin (TeNT) before 
addition of SNAP-25 and syntaxin cleaved nearly the entire pool of synaptobrevin (left 
lanes), documenting that it is completely accessible. 
b) Similar experiment as in a) except that syntaxin with the intact cytoplasmic domain (aa 1-
262) was used. Almost the entire pool of synaptobrevin on synaptic vesicles forms a 
ternary complex with the intact cytoplasmic portion of syntaxin. 
c) and d) SNARE complex assembly monitored by FRET. Syx225TR(100 nM ) and 
Syx225OG (100 nM) were preincubated with SNAP-25 (200 nM) for 1h to allow for the 
formation of the syntaxin/SNAP-25 2:1 complex. Synaptobrevin replaces one of the 
syntaxins to form the ternary SNARE complex. Increasing the amount of synaptic 
vesicles increased the rate of displacement of one molecule of syntaxin from the 
syntaxin/SNAP-25 2:1 complex as seen by donor fluorescence increase and acceptor 
fluorescence decrease, thus indicating that soluble syntaxin and SNAP-25 can form 










3.3.1 SNARE complex formation on synaptic vesicles is not influenced by calcium 
 
Since synaptic vesicles contain the putative calcium sensor (synaptotagmin I), the 
rate of complex formation in the presence or absence of calcium ions was also tested. 
Synaptic vesicles were incubated with syntaxin and SNAP-25 for 30 min, i.e., conditions 
under which complex formation was not complete. No difference was observed in the 
presence of calcium concentrations up to 1 mM (Fig 25a.). Complex formation was also 
monitored on synaptic vesicles over time at various calcium concentrations. As shown in 




Figure 25. SNARE complex assembly on synaptic vesicles does not change in the presence of 
increasing  amounts of calcium. 
Conditions were the same as in Fig. 24a) except that reactions were carried out in the stated 
amounts of calcium. a) SNARE complex assembly monitored by immunoblotting for 
synaptobrevin. Synaptic vesicles were incubated with syntaxin and SNAP-25 for 30 minutes in the 
presence of the indicated Ca+2 concentrations. Note that under these conditions, complex 
formation is not completed (see also Fig. 26). b) SNARE complex assembly over time monitored 
by anti-ternary complex antibody (cl 135.2) indicating that complex formation increased over 













3.3.2 Reactivity of synaptobrevin in liposomes and synaptic vesicles is comparable 
 
In the next experiments, the reactivity of synaptobrevin in proteoliposomes and 
synaptobrevin in synaptic vesicles was compared. To make the reaction rates comparable, 
the amounts of synaptobrevin were matched using approximately twice as much for the 
generation of liposomes in order to account for random orientation. Since endogenous 
synaptobrevin cannot be labeled, the reaction was again monitored by the appearance of 
SDS-resistant SNARE complexes. For complex formation, a fluorescently labeled 
syntaxin variant (Syx225OG) was used, allowing to monitor the reaction both by 
immunoblotting for synaptobrevin and by fluorescence. Addition of SNAP-25 and 
syntaxin to synaptobrevin-containing liposomes or synaptic vesicles, respectively, 
resulted in complex formation at comparable rates, regardless of whether immunoblotting 







































Figure 26. The rates of SNARE complex assembly on synaptic vesicles and on synaptobrevin 
liposomes are comparable. 
Syx225OG and SNAP-25 were incubated with synaptobrevin liposomes or synaptic vesicles (see 
Fig. 24a legend). SNARE complex formation, measured by the appearance of SDS-resistant 
bands, was monitored by immunoblotting for synaptobrevin (left panels) or by measuring 
fluorescence derived from syntaxin (right panels). To ensure that the reactions are completely 
arrested at the end of the incubation, SDS-containing sample buffer was added and the samples 
were immediately shock-frozen, and thawed only immediately prior to SDS-PAGE. For 
quantitation, the intensity of the bands was determined, corrected for background and plotted 







3.4 Soluble syntaxin and SNAP-25 displace synaptobrevin from the  
synaptophysin/synaptobrevin heterodimer to form the ternary 
SNARE complex 
 
In synaptic vesicles, synaptobrevin is complexed with synaptophysin in a manner 
that is mutually exclusive with its interaction with SNAREs (Edelmann et al., 1995; 
Pennuto et al., 2002; Yelamanchili et al., 2005). The possibility that complex formation 
with exogenous SNAREs leads to a dissociation of synaptobrevin from synaptophysin 
was therefore tested.  A fraction enriched in synaptic vesicles was incubated with SNAP-
25 and syntaxin, followed by detergent solubilization and immunoprecipitation of either 
synaptobrevin or synaptophysin. As shown in Fig. 27a, addition of the SNAREs caused a 
massive reduction in the amount of synaptobrevin co-precipitating with synaptophysin. 
Conversely, upon SNARE addition, a similarly strong reduction was observed in the 
amount of synaptophysin that co-precipitated with synaptobrevin (Fig. 27b). These results 
indicate that SNARE complex formation effectively dissociates synaptobrevin from 
synaptophysin. To confirm that synaptophysin does not interact with assembled SNARE 
complexes, complex formation was carried out using fluorescently labeled syntaxin, 
followed by solubilization and immunoprecipitation with synaptobrevin- or 
synaptophysin-specific antibodies, respectively. As shown in Fig. 27c, labelled syntaxin is 
only detectable in the synaptobrevin immunoprecipitates. As an independent read-out for 
the synaptophysin-synaptobrevin complex, which avoids detergent solubilization, I 
employed cross-linking using the bifunctional cross-linker DSS (Edelmann et al., 1995). 
Cross-linking resulted in the appearance of an additional band of approximately 55 kDa 
that was positive for both synaptophysin (Fig. 27d) and synaptobrevin (not shown). 
Incubation of the vesicles with SNAP-25 and syntaxin prior to cross-linking prevented the 
formation of the adduct (Fig. 27d) suggesting that the endogenous synaptobrevin of 
synaptic vesicles is fully active with respect to SNARE complex formation and that it 












Figure 27. Synaptobrevin is displaced from synaptophysin (Syp) upon formation of SNARE 
complexes. 
a, b and c)  An enriched vesicle fraction (LP2, 50 µg of protein) was incubated in the 
presence or absence of 50 µg  fluorescently labeled Syx225TR , 200 µg unlabelled syntaxin 
and 500 µg SNAP-25 for 2h., followed by solubilization in Triton X-100 and 
immunoprecipitation for either synaptophysin (a) or synaptobrevin (b). All samples were 
analyzed by SDS-PAGE a) Immunoblotting for synaptobrevin shows that the amount of 
synaptobrevin coprecipitating with synaptophysin is reduced in the presence of syntaxin 
and SNAP-25  
b) Conversely, immunoblotting for synaptophysin shows that the amount of      
synaptophysin coprecipitating with synaptobrevin is reduced in the presence of   
SNAREs. Note that in both cases the efficiency of antigen immunoprecipitation is 
comparable. 
c) SNARE complexes (visualized by fluorescence of Syx225TR) coprecipitate with 
synaptobrevin but not with synaptophysin. 
d) Disappearance of the synaptophysin-synaptobrevin complex in the presence of unlabelled 
syntaxin and SNAP-25, monitored by cross-linking with DSS, a bifunctional reagent. In 
the absence of the SNAREs, cross-linking results in the appearance of a band of ~55 kDa 
(*)  that is recognized by both synaptophysin- (d) and synaptobrevin-specific (data not 
shown) antibodies and thus represents a  heterodimer (Edelman).  








3.5 Characterisation of monoclonal antibodies against neuronal 
ternary SNARE complex 
 
Monitoring of SNARE complexes within a cell have been done by either over-
expression studies involving fluorescently tagged SNARES (An and Almers, 2004) or by 
the use of toxins that clip individual SNAREs at specific sites, reviewed in (Montecucco 
et al., 2005). The second part of this work involved the characterisation of and subsequent 
assay development with, monoclonal antibodies that recognise the ternary SNARE 
complex but not the individual monomeric SNAREs. The antigen used for immunisation 
was the complex of synaptobrevin (aa 1-96), syntaxin (aa 180-262) and SNAP-25 first 
and second helices. Three antibodies were characterised: 135.1 (subtype IgG1), 135.2 




Figure 28. Binding specificity of anti-ternary complex antibodies to the SNARE complex. 
a) Fluorescently labeled syntaxin (Syx225OG), synaptobrevin (aa  1-96) and SNAP-25 were 
incubated in a molar ratio of 1:1:2 for 1h before SDS-PAGE and immunobloting for 
ternary complex with anti-ternary complex antibodies. Cl 135.1 recognizes only the 
ternary SNARE complexes and not the monomeric SNAREs, i.e., when the complex is 
boiled prior to loading (left). The bands corresponding to the tenary were also visible due 
to fluorescence on syntaxin (right). Boiled complex shows the fluorescently labeled 
monomeric syntaxin. Similar results were obtained with cl 135.2 and cl 135.5 (not 
shown). 
b) Synaptic vesicles preincubated with syntaxin and SNAP-25 in a stoichiometric ratio of 1:1 
when incubated with the anti.ternary complex antibody showed that it bound to it as seen 
by the IgG bands in the Coomassie stained SDS-PAGE. Note that in the control where 






e) Native gel showing that whereas cl 135.1 recognizes ternary complex, it cannot recognize 
a binary complex of syntaxin and SNAP-25.  
 
To test the specificity of the antibodies for the complex, immunoblotting was done 
to determine whether only the complex and not the monomeric SNAREs is recognised by 
the antibodies. Soluble synaptobrevin, syntaxin and SNAP-25 were mixed in the 
stoichiometric ratio of 1:1:2 and pre-incubated for 1h before SDS-PAGE/immunoblotting. 
As shown in Fig. 28a, the antibody (135.1) recognises only the complex and not the 
monomers, as asessed by the immunoblot and fluorescence signal on syntaxin. Similar 
results as in Fig. 28a were obtained for 135.2 and 135.5.  
In some immunoblots using native material, a faint band of approximately 25 kDa 
was visible (not shown). However, the antibodies do not recognise recombinant SNAP-
25. It is possible that during immunoblotting, native SNAP-25 acquires a conformation 
that enables its recognition by the antibodies. 
To further test the binding of the antibodies to the complex, synaptic vesicles were 
pre-incubated with soluble syntaxin and SNAP-25. Antibodies were added to synaptic 
vesicles preincubated or not with syntaxin/SNAP-25. These mixes were pelleted down by 
high speed centrifugation (100,000 x g) and loaded onto SDS-PAGE followed by 
Coomassie staining. As shown in Fig. 28b, synaptic vesicles preincubated with 
syntaxin/SNAP-25 had higher signal for IgG bands of the antibody in the Coomassie-
stained gel. Whereas the ternary complex is resistant to SDS treatment, the binary 
complex between syntaxin and SNAP-25 is not. Therefore, native PAGE followed by 
immunoblotting for the antibodies confirmed that the antibodies recognise only the 











Figure 29. Characterisation of the binding site of the novel monoclonal antibodies 135.1, 135.2 
and 135.5. 
a) 10 µg of all complexes tested were loaded on an SDS-PAGE followed by coomaise 
staining to determine whether they are SDS-resistant. All the bands above the blue line 
represent SDS-resistant SNARE complexes. 
b), c) and d) 200 ng of all proteins (monomers and complexes) were analysed by SDS-
PAGE followed by immunoblotting for the antibodies. tmidi: syx (aa 180-262), syb (aa 1-
96) and SNAP-25, minicomplex: same as tmidi except that the SNAP-25 is without the 
linker between the two SNARE motifs (antigen).  
       b) Cl 135.1 recognizes the N-terminal region of the SNARE complex more strongly. C-
terminal  deletions of the monomeric SNAREs does not affect its capacity to     bind. N-
terminal truncations of monomeric synaptobrevin compromises its capacity to bind the 
complex. 
c) Cl 135.2 recognizes the C-terminal region of the SNARE complex more strongly. 
Whereas N-    terminal deletions of the monomeric SNAREs does not affect its capacity to 
bind, C-terminal truncations of monomeric synaptobrevin compromises its capacity to 
bind the complex. Note that C-terminal truncations of SNAP-25 does not affect its 
binding capacity. 
d) Cl 135.5’s binding preference is similar to that of 135.2 though the binding affinity is 
greatly reduced. 
 
The next set of experiments were done to determine the binding site of the 
antibodies on the complex. Various complexes were generated: those with one of the 
SNAREs replaced with its isoforms and those that had truncations in either the C-terminal 
end or N-terminal end of one of the SNAREs. All complexes that were tested are resistant 
to SDS treatment (Fig. 29a).  SDS-PAGE followed by immunoblotting with the individual 
antibodies revealed that whereas the N-terminal end of the complex was crucial for the 
recognition of 135.1 (Fig. 29b), the C-terminal end of the complex, particularly the C-
terminal end of synaptobrevin, appeared crucial for the recognition of 135.2 and 135.5 







Proteins identified by LC-coupled Electrospray Ionization (ESI) tandem mass spectrometry 
CHAPS extract Triton X-100 extract 
syntaxin-1A [Rattus norvegicus] syntaxin 1A [Rattus norvegicus]  
syntaxin 1B2 [Rattus norvegicus] syntaxin 1B2 [Rattus norvegicus] 
SNAP-25b [Rattus norvegicus] SNAP-25b [Rattus norvegicus] 
vesicle associated membrane protein 2 [Mus 
musculus] 
vesicle associated membrane protein 2 
[Mus musculus] 
ATPase, H+ transporting, lysosomal V0 subunit a 
isoform 1 [Mus musculus]  
ATP synthase gamma-subunit [Rattus 
norvegicus]   
SNAP-25a [Rattus norvegicus] tomosyn isoform m [Rattus norvegicus] 
VAMP-1 [Rattus norvegicus]  complexin 1 [Rattus norvegicus] 
synaptotagmin P65 - [Rattus norvegicus] 
vacuolar-type H(+)-ATPase [Homo sapiens]  
vacuolar adenosine triphosphatase subunit D [Mus 
musculus] 
Figure 30. Immunoprecipitation followed by immunoblotting and mass-spectrometry of 
synaptopsome-enriched rat brain fraction. 
The immunoprecipitates of 135.1, 135.2 and 135.5 were immunoblotted for various antibodies. 
The antibodies for the proteins indicated above produced positive results. Peptide generation by  
trypsinisation of  the Triton X-100 and CHAPS extracted immunoprecipitates of cl 135.1 followed 
by Liquid Chromatography coupled Electrospray Ionization (ESI) tandem mass spectrometry 
analysis resulted in the detection of the proteins listed above. 
 
To determine whether the antibodies specifically bind native neuronal complexes, 
immunoprecipitation of the complexes from a synaptosomal enriched fraction of the brain 
was done. In addition to syntaxin, synaptobrevin and SNAP-25, other SNAREs including 
amisyn, SNAP-29 and cellubrevin and a known binding partner of SNARE complex, 
complexin were detected in immunoblots (Fig. 30). Since the amount of proteins 
immunoprecipitated using 135.1 was the highest among the three antibodies tested, the 
extracts generated using two different detergents, CHAPS and TritonX-100, were used as 
starting material for immunoprecipitation with 135.1. Immmunoprecipitation was 
followed by SDS-PAGE and LC-coupled Electrospray Ionization (ESI) tandem mass 
spectrometry. The immunoprecipitates from the two different detergent extracts were used 
for mass-spectrometry because, owing to the difference in their micellar size  (6.15 kDa 
for CHAPS and 80 kDa for Triton X-100) (SigmaAldrich), there would be differential 
detection of SNARE complex interaction partners. In the immunoprecipitate of the Triton 
X-100 extract, in addition to the three SNARES (syntaxin 1, SNAP-25 and 
synaptobrevin), tomosyn, complexin 1 and ATP synthase gamma-subunit were detected 
(Fig. 30). In the immunoprecipitate of the CHAPS extract, in addtion to syntaxin, 
synaptobrevin and SNAP-25, synaptotagmin  and vacuolar ATPase subunit D were 







Figure 31. Colocalization of ternary complex with membrane resident proteins,SNAP-25 (a) and 
syntaxin (b) and vesicular marker synaptophysin (c). 
Note that like SNAP-25 and syntaxin, ternary complexes are mainly localized on the plasma-
membranes. Also note that the vesicular marker synaptophysin is distributed throughout the cell 
 
In immunostaining on PC-12 cells, 135.2 and 135.5 do not recognise specific 
signals (not shown) but 135.1 produced a punctate plasma membrane staining pattern 
(Fig. 31). To determine whether the recognition of the SNARE complex in a cell is 
specific, membrane patches of BHK cells and PC-12 cells were prepared as described in 
the Methods. In BHK cells, the neuronal SNAREs are absent. Thus the anti-neuronal 
SNARE complex  antibody is expected not to bind to membrane sheets prepared from 
BHK cells. However, immunostaining of BHK cell membrane sheets resulted in some 
background staining (Fig.32, right panel) which was markedly reduced if the primary 







salt (500 mM) (Fig.32, middle panel), implying that though the antibody produces 
background staining, conditions can be controlled for minimising this effect. 
The weak background staining observed in BHK cells, where neuronal SNAREs 
are normally absent suggests that the antibody’s recognition of the antigen is specific, 
though the binding conditions need to be controlled, for instance by ensuring high salt 
concentration (500 mM NaCl) in buffers in the primary antibody incubation and 
subsequent washing steps. 
 
Figure 32. Supressing unspecific background of 135.1 staining on PFA-fixed membrane sheets. 
Membrane sheets were produced from PC-12 cells and BHK cells (lacking neuronal ternary 
SNARE complexes), fixed and immunostained. 40% immunostaining intensity was observed on 
BHK membrane sheets when compared to that of PC-12 cells when incubation periods for both 
primary and secondary antibodies was 2 hr and BSA as a blocker was not applied. Similar results 






blocker prior to antibody incubation. Relative BHK staining intensity could be strongly 
suppressed when the primary antibody and subsequent washing steps were done in the presence of 
500 mM NaCl (see methods for details). Error bars are S.D. (These experiments were done in 
collaboration with T. Lang, MPI-bpc, Göttingen) 
 
It was reported earlier that in PC-12 cells exogenously added synaptobrevin can 
engage plasma membrane syntaxin and SNAP-25 in a complex (Lang et al., 2002). The 
work in this thesis consolidates this finding. A measure of specific binding of antibody to 
the ternary SNARE complex was to determine to what extent incorporated fluorescence-
tagged synaptobrevin correlated with the antibody signal. A high degree of correlation 
was obtained (0.48 +/- 0.6) (Fig. 33), strongly suggesting that the antibody’s capacity to 
recognise SNARE complexes within a cell is high. However the low slope of the plot of 
incorporated fluorescent synaptobrevin versus anti-ternary complex antibody 
immunostaining signal suggests that the increasing signal of synaptobrevin fluorescence 
is disproportionate to that of the anti-ternary complex antibody. A possible explanation 
for this observation is that the anti-ternary complex antibody is occluded from its bonafide 
interaction sites by other factors or by the multimerisation of SNARE complexes, 
resulting a low signal to noise ratio. In contrast, synaptobrevin fluorescent intensity was 
proportionate to the immunostaining of an antibody that recognizes synaptobrevin (Fig. 





























Figure 33. Correlation of signals arising from incorporated fluorescently labelled synaptobrevin 
with anti-ternary complex antibody 135.1 immunostaining (a) or with anti-synaptobrevin antibody 
69.1 immunostaining (b). 
(a and b) Membrane sheets were produced from PC-12 cells. and then reacted with synaptobrevin 
2–Alexa594 in order to form ternary SNARE complexes (red channel) followed by 
immunostaining with 135.1 (a) or 69.1 (b). Lower panels represent magnified views in a and b. 
The third panels in both a) and b) represent overlays from both channels. The correlation 
coefficient of signal of fluorescent synaptobrevin and 135.1 was 0.48 +/- 0.06 (n=3, on average 10 
membrane sheets analysed in each experiment), that of fluorescent synaptobrevin and 69.1 was 
0.72 (15 membrane sheets analysed). 
c) Plotting green against red fluorescence intensity from individual membrane sheets from 
experiments shown in a and b. (These experiments were done in collaboration with Thorsten 
Lang, MPI-bpc, Göttingen) 
3.6 The anti-ternary complex antibodies block disassembly of SNARE 
complexes by NSF/α-SNAP 
Since the antibodies have been shown to bind to the neuronal SNARE complex 
and not to the monomers, it is expected that they should not have a marked effect on the 
assembly of SNARE complex but may impair the disassembly of the complex by NSF/ α-
SNAP. The assembly and disassembly of the SNARE complex was monitored by the 
FRET assay discussed above. Whereas an antibody against SNAP-25 (71.1) which is 
known to block assembly (Xu et al., 1999), does block donor fluorescence quenching of 
SNARE complexes in the FRET assay, none of the monoclonal antibodies against the 
complex blocks assembly either individually or all together (Fig. 34a). An antibody 
against synaptobrevin (69.1), which is known not to interfere with assembly (Lang et al., 
2002), was used as a negative control (Fig. 34a). In the FRET assay developed for 
monitoring disassembly of pre-assembled SNARE complexes by NSF/α-SNAP, whereas 
all the three antibodies tested blocked disassembly to a certain degree, only 135.1 and 
135.2 together blocked disassembly by an appreciable extent (Fig. 34b).  These 
experiments suggest that the concerted block of disassembly of SNARE complex by 
135.1 and 135.2, which probably bind to either end of the SNARE complex could be an 







Figure 34. The anti-ternary complex antibodies can block disassembly of SNARE complexes by 
NSF/a-SNAP but does not abolish SNARE complex assembly, as assessed in a FRET assay. 
a) Assembly of SNARE complex. Whereas purified monoclonal antibody against SNAP-25 
(71.1, final conc. 32 ng/µl), a known inhibitor of SNARE complex assembly (Xu et al., 
1999) blocks donor fluorescence quenching, antibodies directed against synaptobrevin 
(69.1, final conc. 32.4 ng/µl), known not to inhibit assembly (Lang et al., 2002) or against 







(135.5 final conc. 10 ng/µl) alone or all together could not block assembly. (see legend to 
Fig. 11a) 
b) Disassembly of SNARE complex (80 nM final conc. of synaptobrevin28OG (aa 1-96), 
syntaxin aa 180-262, SNAP-25130TR full-length) by NSF (8 nM) /α-SNAP (1.6 µM). 
Although, each of the antibodies 135.1, 135.2 and 135.5 (0.5 ng/µl final concentration) 
blocks SNARE complex disassembly to a certain level, appreciable block was possible 
only when both 135.1 and 135.2 were used in concert. All disassembly reactions were 
carried out in Hepes-NaOH, pH 7.4, 2mM ATP, 5 mM MgCl2, 0.5 % CHAPS. (Figure b 
was contributed by Ulrike Winter, MPI-bpc, Göttingen)  
 
3.7 The anti-ternary complex antibodies do not prevent release from 
permeabilized PC-12 cells 
 
To test whether the antibodies can inhibit release in a functional assay, the 
permeabilized cell assay (Hay and Martin, 1992; Klenchin et al., 1998) was used. 
Permeabilized PC-12 cells have been extensively studied to monitor release under 
different conditions. This assay was adapted to test whether PC-12 cells perfused with 
anti-ternary complex antibodies blocked release of secretory granules. Perforations were 
generated in the PC-12 cells that had been pulsed with [3H] labelled Norepinephrine by 
treatment with Streptolysin-O (Ahnert-Hilger et al., 1993). The perforated cells, pre-
treated with a mixture of all the three antibodies were stimulated for 25 minutes. The 
antibodies were accessible into the permeabilised cells (Fig. 35b). As shown in Fig. 35a, 
the antibodies had no impact on release, suggesting that the releasable pool of vesicles 
had either pre-formed SNARE complexes or SNARE complexes formed upon stimulaton. 
The binding of antibodies to the complexes did not prevent them from fusing membranes. 
Since this assay runs down in a short duration, a second round of release - which is be 


















Figure 35. [3H] Norepinephrine  secretion from Streptolysin-O permeabilized PC-12 cells. 
a) Permeabilized cells were incubated with anti-ternary complex antibodies (135.1, 135.2, 
135.5) or anti-NMDA receptor antibody 54.1 for 12 min prior to stimulation. Then 
calcium and ATP were added and release was measured after 25 min of incubation. None 
of the antibodies inhibited release. Graph shows mean ± SEM (four expts.) 
b) The antibodies have access into pearmeabilised cells. SLO-permeabilized (left) and non- 
permeabilized (right) cells were incubated with 135 antiobodies as in the release assay 
followed by detection with a Cy3 conjugated secondary antiobody. 


















3.8 Preliminary results suggest that the total amount SNARE complex 
in a resting cell and stimulated cell is comparable 
Does the amount of SNARE complex in a cell increase when it has been 
stimulated or does the cell’s disassembly machinery - NSF/α-SNAP – act immediately 
after exocytosis has occurred to maintain the concentration of SNARE complex in a cell? 
Previous reports have indicated that under resting conditions, the amount of SNARE 
complex can be significantly increased (Lonart and Sudhof, 2000). To determine whether 
SNARE complexes accumulate in synaptosomes that have been stimulated, an assay that 
can measure SNARE complexes directly is most suited. The novel antibodies discussed in 
this thesis provide an excellent tool to measure SNARE complexes in native membranes. 
Synaptosomes prepared from rat brains were stimulated by the application of either KCl 
or ionomycin, a Ca+2 ionophore. To test whether the synaptosomes treated with KCl or 
ionomycin had indeed been stimulated, the synaptosomes were subjected to osmotic lysis 
and separated into a plasma membrane rich (LP1) and a vesicle enriched fraction (LP2) 
followed by SDS-PAGE and immunoblotting for Rab3a, a small GTPase known to 
dissociate from vesicles upon stimulation (Fischer von Mollard et al., 1991). As shown in 
Fig. 36, in 50 mM KCl or 10 µM ionomycin treated synaptosomes, the amount of Rab3a 
reduced by almost 60% in the vesicular fraction whereas it remained unchanged in 
unstimulated synaptosomes. In both stimulated and unstimulated synaptosomes, 
comparable amount of SNARE complexes were present (Fig. 36 c), suggesting that they 


















Figure 36. Are ternary complexes dissociated before or after synaptic vesicle endocytosis? 
Synaptosomes were generated from rat brain. They were stimulated by the addition of high 
potassium or ionomycin. To monitor ternary complexes, synaptosomes were loaded directly onto 
the gel. To assess whether synaptosomes had indeed been stimulated,  they were ruptured via 
hyperosmotic shock. Large membranes were pelleted by differential centrifugation (LP1). 
Synaptic vesicles and newly endocytosed vesicles were then pelleted by prolonged high speed 
centrifugation (33,000 g, LP2). 
a) Typical immunoblots of stimulated and unstimulated synaptosomes , ice (synaptosomes 
kept on ice), EGTA (synaptosomes incubated at 37oC in the presence of EGTA), KCl 
(synaptosomes incubated with 50 mM KCl in the presence of Ca+2 at 37oC), ionomycin 
(synaptosomes stimulated with 10 µM ionomycin in the presence of Ca+2 at 37oC). 









b) Efficiency of stimulation. Rab3a dissociates from synaptic vesicles during the fusion 
process (Fischer von Mollard et al., 1991). Note the loss of Rab3a in ionomycin or KCl 
conditions. Graph shows mean ± SEM, four experiments. Densitometry was performed on 
LP2 fractions. 
c) Ternary complex does not increase in the stimulated synaptosomes. Synaptosomes were 
stimulated as above and the amount of ternary complex was quantified (mean ± SEM, 
four experiments). Note that the total amount of complex remains unchanged despite 
massive exocytosis. 
 
3.9 SNARE complexes are present on synaptic vesicles 
 
That vesicle endocytosis occurs even before SNARE complexes are disassembled 
on the plasma-membrane is a distinct possibility. Immunoblotting of subcellular fractions 
of rat brain revealed substantial amount of SNARE complexes in the vesicular fraction 
(Fig. 37d). Furthermore, direct imaging of isolated vesicles revealed that a majority of 
synaptic vesicles (about 80%) have ternary complexes on them (Fig. 37a and c). The 
intensity of the signals due to anti-ternary complex antibodies on these vesicles was 
markedly lower than that of vesicle resident proteins like synaptophysin, indicating that 
very few copies of ternary complexes were present on the vesicles. It cannot be ruled out 
though that SNARE complexes form on isolated vesicles when they are not subjected to 






















Figure 37. A large fraction of synaptic vesicles binds anti-ternary complex antibodies. 
Synaptosomes were prepared according to (Nicholls and Sihra, 1986), and a synaptic vesicle-
enriched fraction was prepared (LS1). The vesicles were labeled in suspension with 135.1 
antibodies, centrifuged onto glass coverslips, further labeled with G96 rabbit anti-synaptophysin 
antibodies, and finally stained with fluorescently labeled goat anti-mouse and anti-rabbit 
antibodies.  
a) Images were acquired in the green (135.1) and red (G96) channels, the two frames were 
aligned using Tetraspeck beads, and then shifted by 5 pixels in the X axis, to indicate the 
colocalizing green and red spots (marked by arrows). Some vesicles (identified by the 
bright G96 staining) do not exhibit 135.1 staining (arrowheads).  
b) 24-pixel long line scans were drawn through the centers of randomly selected G96-
positive organelles; the intensities in the green and red channels along the scans were 
obtained and plotted as in the example above. The correlation between the two 
fluorescence distributions was then measured (see Methods).  
c) c) The percentage of highly correlating spots (correlation coefficient higher than 0.8) was 
obtained for the experimental condition. Positive control represents synaptic vesicles 
labeled for synaptophysin and stained with two differently colored secondary antibodies; 
negative controls represent the correlation between images obtained in the red channel 
and the mirror images of the green channel. N=3 independent experiments for each 
condition (means +/- SEM). 
d) Subcellular distribution of Ternary SNARE complex.  Brain subcellular fractions (10 
µg/lane) were analyzed by SDS-PAGE followed by immunoblotting for anti-ternary 
complex antibody 135.1 .P1, low speed (nuclear) pellet P2`, enriched synaptosomal 
fraction; LP2, enriched synaptic vesicles; LP1, membrane pellet obtained after hypotonic 
lysis of P2`; P1, low speed (nuclear) pellet; pool 1, large organeller fraction. For details of 









Genetic, physiological and biochemical studies have established the role of 
SNARE proteins at a late stage of exocytosis (references in Introduction). SNARE 
complex formation is accompanied by a large enthalpy of binding of unstructured 
monomeric SNAREs (Fasshauer et al., 2002). This energy can be transduced via the 
linker regions of SNAREs to the membranes, perturbing them thereby and inducing 
fusion (Knecht and Grubmuller, 2003). 
        In vitro studies using soluble domains of SNAREs have shown that SNARE 
complex formation is spontaneous and irreversible (Fasshauer et al., 1997b). The complex 
thus formed is kinetically stable and there appears to be no additional input of energy in 
the fusion reaction. The free energy of assembly cannot be measured due to a marked 
hysteresis, i.e., SNARE complex assembly and disassembly pathways are divergent 
(Fasshauer et al., 2002). The kinetic stability of the SNARE complex is ideally suited to 
ensure that trans-complex formation, once initiated, is brought to completion. The 
monomeric SNAREs are regenerated for another round of fusion by the AAA+ ATPase 
NSF and its co-factor α-SNAP (Sollner et al., 1993a; Sollner et al., 1993b).  
      Synaptobrevin 2 is the R-SNARE localized to synaptic vesicles. Mice that are 
deficient in synaptobrevin have severely impaired evoked neurotransmitter release 
(Schoch et al., 2001). Synaptobrevin is also the target for most of the clostridial 
neurotoxins that target the SNAREs, Botulinum toxins B, D, F, G and Tetanus toxin, 
underscoring the importance of this protein in neuronal physiology, reviewed in 
(Breidenbach and Brunger, 2005). Synaptobrevin comprises about 10% of all proteins (or 
60-70 copies) on a single synaptic vesicle (Takamori unpublished observations). The 
regulation of such an abundant and reactive molecule is therefore of paramount 
significance.  
      Studies on double knock-out mice lacking synaptobrevin and another R-SNARE, 
cellubrevin have revealed that the non-conserved N-terminal domain of synaptobrevin 
(residues 1-32) regulates the priming activity of synaptobrevin (Borisovska et al., 2005). 
The N-terminal domain of synaptobrevin is proline rich and is therefore a potential target 
for regulatory molecules though no such factor is known. The determination of such a 







as suggested for SNAP-25 (Hess et al., 1992; Koticha et al., 2002; Lane and Liu, 1997; 
Nagy et al., 2002; Nagy et al., 2004) and syntaxin (Betz et al., 1997; Dulubova et al., 
1999; Sassa et al., 1999), the regulatory domain on synaptobrevin may not be solely 
encoded in the SNARE motif. The specificity of pairing of its SNARE domain, the 
interactions of its membrane-proximal region with the membrane and/or other regulatory 
factors and the dynamics of its trans-membrane region may confer additional regulatory 
features on synaptobrevin. 
        SNAREs may be regulated by the specificity of SNARE pairing. Soluble R-
SNAREs, tomosyn and amisyn, bind syntaxin and SNAP-25 resulting in fusion-
incompetent complexes (see Introduction). Synaptobrevin cannot replace tomosyn 
(Pobbati et al., 2004) or amisyn (Pobbati, PhD thesis) to form the fusogenic complex with 
syntaxin and SNAP-25 ensuring that the number of fusion competent acceptor complexes 
between syntaxin and SNAP-25 is tightly controlled. The existence of non-cognate 
SNARE complexes could thus be a means of fine-tuning SNARE regulation.  
Liposome fusion experiments carried out by Rothman and colleagues led to the 
proposal that the specificity of fusion is determined by the SNAREs (McNew et al., 2000; 
Parlati et al., 2000). Another study has, however, shown that both cognate and non-
cognate SNAREs engage to form complexes (Fasshauer et al., 1999). Moreover, several 
SNAREs may be operating in more than one pathway, for instance, vesicles bearing Snc1 
or Snc2 can fuse with plasma membrane, trans-golgi network and early endosomes 
(McNew et al., 2000; Paumet et al., 2004). In synaptobrevin knock-out mice, cellubrevin 
expression is up-regulated by 36% (Borisovska et al., 2005). Likewise, in cellubrevin 
knock-out mice, the expression of synaptobrevin is up-regulated by 27% (Borisovska et 
al., 2005). These results, among other similar studies in yeast and Drosophila 
(Bhattacharya et al., 2002; Liu and Barlowe, 2002; Vilinsky et al., 2002) suggest that 
SNAREs can compensate the deficiency of their isoforms to a certain extent. It is 
therefore possible that there is a degree of functional redundancy among SNARE proteins.  
The evolutionary design of the synaptic SNAREs is best suited to orchestrate 
neuronal exocytosis with precise kinetics. Each of the synaptic SNAREs has structural 
features that subject it to regulation. In this study, the activity of synaptobrevin in 
membranes was studied. In the second part of this study, an antibody raised against the 
neuronal SNARE complex was characterised and the status of the SNARE complex in a 






4.1 Synaptobrevin in membranes is fully active 
 
It has been suggested that synaptobrevin is under direct regulation by the 
membrane (Kweon et al., 2003b). In a separate study, synaptobrevin in synaptic vesicles 
was suggested to be inhibited from interaction with syntaxin and SNAP-25 (Hu et al., 
2002). Together, these findings suggest that synaptobrevin in membranes is intrinsically 
inactive and that it has to be activated by the calcium sensor, synaptotagmin, prior to 
SNARE complex assembly. 
In the present study, exogenously added SNAP-25 and syntaxin were capable of 
driving surface-exposed synaptobrevin (as measured by its susceptibility to the protease 
Tetanus toxin) completely into SNARE complexes.  
The differences in the results in my study and that of Kweon et al. are noteworthy. 
Shin and colleagues found no measurable binding of synaptobrevin to partner SNAREs, 
as assessed by electron paramagnetic resonance studies (Kweon et al., 2003b). Though the 
phospholipid composition and protein : lipid ratio was somewhat different to that used in 
my study, I observed SNARE complex assembly to a measureable degree in liposomes 
made of different lipid compositions. Since the reconstitution procedure used by Shin and 
colleagues was different, using insertion of protein into preformed liposomes instead of 
simultaneous reconstitution from micellar solutions, in a pilot experiment using a protocol 
similar to that of Kweon et al, I again found no evidence for inactivation of synaptobrevin 
(not shown).  
The results also suggested that 1) synaptobrevin activity on membranes is an 
intrinsic property of SNAREs, i.e, given the correct physical environment, synaptobrevin 
in membranes spontaneously engages syntaxin and SNAP-25 in a complex and 2) like 
other protein-protein interactions, synaptobrevin binding to its partner SNAREs is 
stabilised by weak counter-ions.  
An interesting observation was that synaptobrevin became refractory to SNARE 
complex formation after prolonged storage or after frequent freeze-thaw cycles. 
Synaptobrevin on these liposomes could not be cleaved by Tetanus toxin light chain. 
Investigation by electron microscopy (not shown) revealed that aged and frequently 
frozen-thawed liposomes tended to clump together and form larger clusters, thus 







I was also unable to reproduce the findings of Davletov and colleagues who 
reported that membrane-anchored synaptobrevin, either reconstituted in liposomes or in 
purified synaptic vesicles was unable to form complexes with exogenous syntaxin and 
SNAP-25 unless detergent was added (Hu et al., 2002). Though we have no obvious 
explanation for the discrepancy between our results and that of Davletov and colleagues, 
it is conceivable that the differences in protein purification and vesicle enrichment 
protocols may account for some of the differences. It is noteworthy that Hu et al. 
extracted the proteins from preparative SDS-PAGE. Since SDS binds to hydrophobic 
sufaces very tightly, it may not be possible to unbind SDS by simple dialysis. SDS bound 
to SNARE proteins would interefere with SNARE complex assembly. 
Several laboratories reported that synaptobrevin-containing liposomes readily fuse 
with liposomes containing SNAP-25 and syntaxin, a reaction that clearly requires active 
synaptobrevin (Schuette et al., 2004; Tucker et al., 2004; Weber et al., 1998). In the 
liposome fusion assays used by researchers as a way of mimicking intra-cellular 
membrane fusion events, however, it has not been clear how active the SNAREs are. In 
the present study, the reactivity of synaptobrevin in synaptic vesicles and lipsomes were 
shown to be comparable implying that the propensity of synaptobrevin in membranes to 
engage partner SNAREs, syntaxin and SNAP-25 in a complex is its intrinsic property, 
uninfluenced by other proteins, as suggested by previous studies (Chen et al., 2004; Hu et 
al., 2002; Hu et al., 2003; Kweon et al., 2003b; Quetglas et al., 2000). 
The proposed inaccessibility of synaptobrevin for complex formation also does 
not explain the action of clostridial neurotoxins that readily cleave membrane-bound 
synaptobrevin both in liposomes and in synaptic vesicles. In order to cleave 
synaptobrevin, clostridial neurotoxins require access to most of the cytoplasmic domain 
of synaptobrevin, for instance the cocrystal structure of synaptobrevin bound to botulinum 
neurotoxin type B at 2.0 Å resolution showed that BoNT B has extensive interactions with 
residues N-terminal to the  cleavage site 76-77 (Hanson and Stevens, 2000). The present 
study provides a convenient explanation for these findings by showing that the 









4.2 Role of membrane-proximal tryptophan residues of synaptobrevin 
 
The reason for the inaccessibility of synaptobrevin to soluble cognate SNAREs  
was assigned to the membrane-dipping of the membrane-proximal residues (aa 85-92). 
These residues were suggested to form an amphipathic helix dipping into the membrane at 
an angle of 33o mediated by interfacial tryptophan residues (Kweon et al., 2003b). The 
studies by Shin and colleagues who reported that insertion of the membrane-proximal 
region of synaptobrevin into the membrane is responsible for its inactivation implies that 
if tryptophan residues are replaced by smaller, polar amino acids, the block by the 
membrane would be relieved and SNARE complex formation would be markedly 
accelerated. In the present study though, I was unable to detect any difference in SNARE 
complex formation rate between wild type synaptobrevin and a mutant in which two 
conserved membrane-proximal tryptophan residues were replaced by serines. 
Surprisingly, no such inactivation was observed by Shin and colleagues for the 
yeast synaptobrevin homolog Snc2p, and spin-labeling of the membrane proximal region 
of Snc2p suggested that this region is not membrane-inserted (Chen et al., 2004). Since 
Snc2p is involved in constitutive secretion, it was proposed that the structural difference 
between Snc2p and synaptobrevin membrane-proximal regions represents the difference 
between constitutive and regulated secretion (Chen et al., 2004). This hypothesis proposes 
that whereas R-SNAREs involved in constitutive secretion would be constitutively active, 
R-SNAREs involved in regulated exocytosis would require an activation step. This 
activation was proposed to be carried out by the calcium sensor, synaptotagmin (Hu et al., 
2002).  
The membrane-proximal tryptophan residues suggested to be critical for 
synaptobrevin inactivation are conserved between synaptobrevin and Snc2p. It is 
intriguing that such divergent roles would arise for very highly conserved residues, as 
illustrated in the sequence alignment below, in proteins belonging to the same sub-family. 
It is not rare for tryptophan residues to be found near the membrane-water interface in 
many single-spanning membrane proteins. In such proteins, they are part of characteristic 
belts containing both basic and aromatic residues near the membrane-water interface 
(Killian and von Heijne, 2000). The indole side chain of tryptophan is ideally suited for 
interacting with polar-apolar membrane-water interface. Whereas the large hydrophobic 






group attached to this aromatic ring can interact with the polar environment of the 
interface. Such a property can also be suggested for tyrosine. Not surprisingly, the 
membrane-proximal residue of synaptobrevin (aa 88) is tyrosine. In addition, the 
positively charged amino acids Lys and Arg might be expected to have a special 
interaction with the interface. Whereas the positively charged residues can ‘snorkel’ into 
the phospholipids head groups, the polar-aromatic residues penetrate into a region near 
the lipid carbonyls (Killian and von Heijne, 2000).  
 







Note that the membrane-proximal tryptophan residues are highly conserved across specis, 
irrespective of the proteins being involved in constitutive or regulated exocytosis. MuMu: Mus 
musculus, AsPa: Aspergillus parasiticus, AsNig: Aspergillus niger, ScPo: Schizosaccharomyces 
pombe, SaCe: Saccharomyces cerevisae, KlLa: Kluyveromyces lactis, HyJe: Hypocrea jecorina, 
NeCr: Neurospora crassa, GiZe: Gibberella zeae, HiMe: Hirudo medicinalis, LySt: Lymnea 
stagnalis, ScJa: Schistosoma japonicum, CaBr: Caenorhabditis briggsae, CaEl: Caenorhabditis 
elegans, StPu: Strongylocentrotus purpuratus, GaGa: Gallus gallus, DaRe: Danio rerio, RaNo: 
Rattus norvegicus, HoSa: Homo sapiens, MaMu: Macaca mulatto, OrCu: Orycytolagus cuniculus, 
XeLa: Xenopus laevis, XeTr: Xenopus tropicalis, DrPs: Drosophila psuedoobscura, DrMe: 
Drosophila melanogaster. The numbering is derived from the protein with the longest sequence. 
 
Though the function of the polar-aromatic residues is not entirely understood, they 
might maintain the vertical position of the single transmembrane helix relative to the 
membrane-water interface (Ridder et al., 2000). Another more likely function for the 
polar-aromatic residues is that together with the positively charged amino acids, Lys and 
Arg, they serve to maintain the orientation of the protein (Ridder et al., 2000). Such a 
pattern has been discerned in many type two single spanning proteins and is not 
characteristic for synaptbrevin (Arkin and Brunger, 1998; Landolt-Marticorena et al., 
1993). The proposed difference between modes of exocytosis assigned to structural 
difference of the membrane-proximal regions is therefore difficult to reconcile with the 
fact that this region is highly conserved in nearly all synaptobrevin homologs. 
4.3 Synaptobrevin readily dissociates from synaptophysin to form 
SNARE complex with soluble syntaxin and SNAP-25 
 
Synaptobrevin may be regulated by its interaction with other proteins such as 
synaptophysin. Synaptobrevin is known to be complexed with synaptophysin in the 
vesicle membrane (Calakos and Scheller, 1994; Edelmann et al., 1995; Washbourne et al., 
1995). Synaptophysin together with its homolog, synaptogyrin constitutes about 10% of 
total vesicular protein pool (Janz et al., 1999). Interest in synaptophysin and its homolog 
has dwindled because of the lack of visible phenotype in synaptophysin knock-out 
(McMahon et al., 1996) and synaptophysin/synaptogyrin double knock-out animals (Janz 
et al., 1999). It is still possible that these proteins are involved in fine-tuning synaptic 
transmission or are involved in post-fusion activity.  
Although neither the regions of synaptobrevin involved in binding to 
synaptophysin nor the stoichiomety of the complex is known in detail, binding appears to 






binding is due to interactions between the transmembrane domains (Edelmann et al., 
1995; Yelamanchili et al., 2005). The trans-membrane region of synaptobrevin is known 
to form heterodimer with that of syntaxin via contiguous areas of interfacial residues 
(Laage et al., 2000; Margittai et al., 1999). The transmembrane region of SNAREs is 
considered to be important for fusion because SNAREs geranylgeranylated at their C-
terminal end are dominant inhibitors of fusion (Grote et al., 2000) and SNAREs with their 
trans-membrane region replaced with phospholipids are unable to support fusion (McNew 
et al., 1999; Melia et al., 2002). Therefore the interaction of synaptobrevin with 
synaptophysin by trans-membrane region may be functionally relevant. 
The synaptobrevin-synaptophysin complex dissociates during exocytosis. This 
dissociation is mediated by cytoplasmic factors that are activated during calcium influx, 
i.e. it does not depend on membrane fusion (Reisinger et al., 2004). While it is well 
established that the interactions of synaptobrevin with synaptophysin and the SNAREs 
syntaxin 1 and SNAP-25 are mutually exclusive (Edelmann et al., 1995; Pennuto et al., 
2002; Yelamanchili et al., 2005), it was not known whether dissociation from 
synaptophysin is a pre-requisite for SNARE complex formation or whether SNARE 
binding triggers dissociation of the complex. The data in this thesis is largely in 
agreement with the second alternative, though the first possibility cannot be completely 
ruled out. 
4.4 Kinetic modelling of SNARE complex assembly 
 
Studies on the assembly pathway of soluble SNAREs have led to the conclusion 
that the 1:1 syntaxin/SNAP-25 complex is a true intermediate in the formation of the 
ternary SNARE complex (Fasshauer and Margittai, 2004). The kinetics of assembly of 
SNARE complex and its intermediates on membranes, where they are naturally found in 
the cell, has not been determined. 
           The reaction on the membrane qualitatively mimics that of soluble SNAREs: 
increasing the amount of SNAP-25 enhances the rate of complex formation. The overall 
reaction rate on membranes is, however, significantly lower than that of soluble SNAREs, 
raising the possibility that the proteins may behave differently on membranes.  
Two solutions of reaction rates for the intermediates and product were arrived at 
by kinetic simulations of SNAP-25 titration experiments,  referred to as solution 1 and 






acceptor was similar to that of the published values for soluble SNAREs. In marked 
contrast to the soluble proteins, the syntaxin2/SNAP-25 binary complex was considerably 
suppressed during the reaction. The binding of synaptobrevin to syntaxin/SNAP-25, 
though twenty times faster than that of syntaxin, was still considerably slow. This means 
that synaptobrevin in membranes, though not inhibited, is greatly retarded from complex 
formation with the syntaxin/SNAP-25 acceptor complex. It is conceivable that this 
retardation in synaptobrevin binding to syntaxin/SNAP-25 is due to synaptobrevin 
dimerization or as suggested by Kweon et al (Kweon et al., 2003b), the 33o tilt into the 
membrane mediated by the membrane-proximal tryptophan residues of synaptobrevin 
renders it incapable of contacting its binding partners. The model proposed by Shin and 
colleagues implies that relieving the membrane block imposed by tryptophans by small 
polar residues would considerably enhance the rate of reaction. However, in this study, 
the rate of complex formation by wild-type synaptobrevin and W89S W90S 
Synaptobrevin was comparable. A possibility for the slow rate of complex formation is 
that synaptobrevin is inaccessible due to dimerization. However, synaptobrevin 
dimerization is an unlikely possibility for the slow rate of complex formation because two 
successive studies indicated that dimerization is a relatively weak interaction with a 
dissociation constant of 10 mM, rendering it mechanistically irrelevant (Bowen et al., 
2002; Kroch and Fleming, 2006). 
 In the second solution, the Kon for syntaxin/SNAP-25 and syntaxin2/SNAP-25 
were comparable to that of soluble proteins. The binding rate of synaptobrevin to the 
syntaxin/SNAP-25 acceptor complex was rapid (on the order of 105 to 106 M-1s-1). The  
Koff for syntaxin/SNAP-25 complex being 100 times faster than that of the proteins in 
solution, the overall reaction rate appeared to be very slow. Two aspects of solution 2 are 
especially noteworthy. One, the syntaxin/SNAP-25 acceptor complex appears to be short- 
lived in the presence of synaptobrevin-containing liposomes. The concentration profile of 
reaction intermediates and products revealed that this complex does not pre-dominate in 
the reaction. Two, the binding of synaptobrevin to the syntaxin/SNAP-25 acceptor 
complex was very rapid. When the synaptobrevin-containing liposomes were solubilized 
by detergent, the rate of reaction was only moderately enhanced suggesting that 
synaptobrevin’s interaction with the membrane (Kweon et al., 2003a) may not affect its 







fragment of synaptobrevin (synaptobrevin 42-96) was added to synaptobrevin bearing 
liposomes, rapid binding of synaptobrevin to this complex was observed (not shown)  
suggesting that synaptobrevin in liposomes is fully active and capable of engaging soluble 
partners in a complex.  
Together, this study establishes that synaptobrevin is capable of engaging its 
cognate binding partners in a complex. The kinetic simulations and deconvolution of 
SNAP-25 titrations experiments carry forward the view that synaptobrevin, even on 
membranes, binds to the syntaxin/SNAP-25 1:1 acceptor complex. It is still not clear 
though, whether membrane fusion in vivo proceeds after an inhibitory block is removed 
from partially zipped complexes (Figure 38, path 1) or whether complex formation 
nucleating at the N-terminal ends drives SNAREs into a full complex resulting in fusion 
(Figure 38, path 2).  The former proposal is supported by studies involving clostridial 
neurotoxins: toxins that normally target N-terminal regions of SNAREs were ineffective 
in blocking nerutransmitter release because the target sites were occluded in the complex 
but toxins that target the C-terminal regions of SNAREs effectively blocked exocytosis 
(Hua et al., 1998). A potential weakness of this model is that no molecule that selectively 
blocks SNAREs in a partially zippered state has been identified. If the syntaxin/SNAP-25 
complex in vivo is labile, as assessed by solution 2 kinetic simulation in this study, it is 
probable that the syntaxin/SNAP-25 complex is stabilised in vivo by an accessory factor 
or by the membrane itself. The stabilisation  on the membrane may be mediated by the 
trans-membrane region of syntaxin and palmitoylation on the SNAP-25 linker region. 
However, the kinetics of in vitro reconstituted fusion assays has been on a minutes to 
hours time-scale, begging askance for a model in which stability is conferred upon solely 
by the membrane. When syntaxin/SNAP-25 complex was stabilised by c-terminal 
synaptobrevin (aa 42-96), rapid fusion was observed (Pobbati, PhD thesis). It is therefore 
more likely that in vivo, the syntaxin/SNAP-25 complex is stabilised by another protein. 
In the primed state of the vesicle, synaptobrevin may be prevented by this protein from 
interacting with syntaxin/SNAP-25. Upon calcium entry, the regulatory factors preventing 
SNAREs from engaging would dissociate from syntaxin/SNAP-25 and rapid complex 










Figure 39. Putative models for synaptobrevin binding to the syntaxin/SNAP-25 acceptor 
complex. 
The kinetic scheme of SNARE complex assembly postulates a syntaxin/SNAP-25 heterodimer 
being a receptor for synaptobrevin. The binding of synaptobrevin to the syntaxin/SNAP-25 
acceptor complex nucleates at the N-terminal ends but is blocked midway by constraints imposed 
by an unknown factor (1). Calcium elevation would drive out the unknown factor and full 
zippering of the complex would lead to fusion. Alternatively, the nucleation of the 
syntaxin/SNAP-25 acceptor complex with synaptobrevin is blocked by an unknown factor, which 
also stabilizes the acceptor complex (2). Upon calcium elevation, the unknown factor would 
depart allowing rapid onset of synaptobrevin binding to the acceptor complex, zippering all the 
way to the C-terminal end of the SNARE motifs, transducing energy though the linker regions and 









4.5 Anti-ternary complex antibodies: new tools for studying SNARE  
complexes 
 
Inside the cell, SNARE complexes are amenable to visualization by FRET when 
the SNAREs are tagged to a fluorescent protein (An and Almers, 2004). In biochemical 
experiments, the amount of SNARE complex is estimated by the stoichiometry of 
individual SNAREs (Fasshauer et al., 1997b). The monoclonal antibody cl 69.1 
(Edelmann et al., 1995) directed against synaptobrevin can also recognise synaptobrevin 
in the complex although by using this antibody within a cell, one cannot distinguish 
between synaptobrevin and ternary SNARE complex. Thus in immunocytochemical 
experiments, direct recognition of the ternary SNARE complex without genetic 
manipulation has not been possible. In order to be able to correctly estimate and visualise 
SNARE complexes within a cell, three monoclonal antibodies directed against the 
SNARE complex were successfully raised and characterised.  
The inhibition of disassembly of SNAREs by NSF/α-SNAP by the antibodies will 
probably be useful in functional assays. Three α-SNAP molecules have been reported to 
bind to the SNARE complex (Marz et al., 2003). It is possible that the antibodies block 
the binding of α-SNAP to the SNARE complex since certain level of disassembly was 
possible when all the three antibodies were added separately, it is suggestive of the 
disassembly machinery functioning even if two α-SNAP molecules are bound to the 
SNARE complex. Together, these data suggest that disassembly occurs by a robust 
mechanism and the disassembly machinery is not selective for either end of the complex. 
4.6 SNARE complexes dissociate immediately after exocytosis 
 
Vesicle fusion with the plasma membrane leads to cis-SNARE complexes on the 
membrane. These complexes are disassembled into their monomeric components by the 
NSF/α-SNAP machinery. Since SNARE complexes are also found on synaptic vesicular 
membranes (Otto et al., 1997), it is not known at which stage of the exo-endocytosis cycle 








plasma membrane have been found on synaptic vesicles (Koh et al., 1993; Walch- 
Solimena et al., 1995).  However, this internal fraction of syntaxin 1 is excluded from 
synaptic vesicles that undergo activity dependent recycling (Mitchell and Ryan, 2004).   
Südhof and colleagues reported that under resting conditions, the amount of 
SNARE complexes and the readily releasable vesicle pool in superfused synaptosomes 
increases when it is treated with NEM implying that SNARE complexes are assembled 
prior to release (Lonart and Sudhof, 2000). In the present study, however, the amount of 
SNARE complexes in stimulated and unstimulated synaptosomes was comparable  
suggesting that SNARE complexes disassemble rapidy following exocytosis. It cannot be 
ruled out, however, that complexes form after solubilization of synaptosomes. 
Immunostaining of a synaptic vesicle enriched fraction (LP2) showed the presence 
of SNARE complexes on a majority of vesicles although the copy number of SNARE 
complexes per vesicle was much reduced when compared with more abundant vesicle-
resident proteins. Furthermore, in immunoblots of various sub-cellular fractions, 
significant amount of SNARE complexes on vesicles were found. These data support 
previous reports of SNARE complexes on vesicles (Otto et al., 1997), though it cannot be 
ruled out that SNARE complexes form on isolated vesicles.  
  Together, these findings suggest that the number of SNARE complexes in a cell is 
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Summary and Conclusions 
 
The data in this thesis show that the cytoplasmic domain of synaptobrevin is 
reactive when the protein is membrane-anchored in liposomes as well as in its native 
resident membrane, laying to rest any speculation about its apparent refractory nature. I 
have amply demonstrated that the neuronal SNAREs are constitutively active, i.e. there is 
no need for an energy-consuming activation step prior to fusion, with the probable 
exception of disassembly mediated by NSF to make monomeric SNAREs available for 
fusion. This does not exclude the possibility that SNAREs are directly controlled by 
interaction with other proteins. These interactions cannot be very tight, and such control 
proteins may rapidly dissociate during the late stages of exocytosis. That synaptobrevin 
dissociates from synaptophysin to form the SNARE complex, as was clearly 
demonstrated in this work, is a clear instance of this premise. Weak binding of regulators 
is favourable since the energy costs for dissociation of the regulators would be low, thus 
preserving the energy stored in the unfolded free SNARE motifs for the execution of the 
fusion reaction. Thus, it would be most economical to control the initial contact of the 
SNARE partners. However, since the energy landscape of the N → C terminal assembly 
pathway is not yet known, it is conceivable that SNARE assembly may be arrested after 
initial trans-contact has been established. Such a scenario is very attractive for neuronal 
exocytosis because it would allow very fast triggering of membrane merger. 
The assembly of SNAREs on membranes follows a pathway similar to that of the 
soluble versions of the proteins. SNARE complex formation is greatly retarded when 
syntaxin with the intact N-terminal domain (Habc domain) is used instead of syntaxin with 
only the SNARE motif. Moreover, synaptobrevin binds to the pre-assembled 
syntaxin/SNAP-25 acceptor complex.  Kinetic simulations of the SNAP-25 titrations data 
provide two alternative explanations for the slow rate of assembly on the membranes: 
one, the binding of synaptobrevin in membranes to the syntaxin/SNAP-25 acceptor 
complex is indeed slow and two, synaptobrevin binds to the acceptor complex rapidly but 
the stability of the acceptor complex is compromised. The latter possibility is amply 
supported by other experimental findings; for instance, synaptobrevin in membranes binds 
rapidly to an acceptor complex stabilised by a C-terminal peptide.  
SNARE complex formation on liposomes reconstituted with synaptobrevin is very 
robust, largely unaffected by endogenous and extraneous factors.  The complex formation  
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rate on synaptic vesicles and reconstituted liposomes is comparable. The complex 
formation rate, however, is enhanced in the presence of weak counter ions, which is 
typical of protein-protein interactions. I also demonstrated that complex formation on 
synaptic vesicles is unaffected by calcium, calling into question the proposed role of the 
calcium sensor, synaptotagmin I (Hu et al., 2002), in relieving the proposed membrane-
block of synaptobrevin (Kweon et al., 2003b).  
In the second part of the study, three monoclonal antibodies which selectively 
recognize the ternary SNARE complex but not the monomers were successfully raised 
and characterised. The binding sites of the antibodies were mapped by immunoblotting 
for a range of SNARE complexes carrying either a replacement of one of the partners or 
truncations of one of the SNAREs from either the N-terminal or the C-terminal end. 
Whereas one of the antibodies depended more on the stability of the N-terminal end of the 
complex for optimum binding, two antibodies preferred the C-terminal end for optimum 
binding. The ternary complex has a typical plasma membrane staining and was largely 
specific for the complex, as assessed by labelling studies on plasma-membrane sheets. 
In a functional assay designed to monitor disassembly by NSF/α-SNAP, each of 
the three antibodies blocked disassembly to a certain extent but appreciable block was 
possible only when two antibodies, one recognizing the N-terminal end and the other 
recognizing the C-terminal end, were used in concert. These data indicate that the 
disassembly process is very robust and the disassembly machinery does not have a 
preference for either end of the complex. However, in a permeabilized PC-12 cell assay 
designed to monitor release, the antibodies neither retarded nor potentiated release, 
indicating that this assay cannot monitor release in subsequent rounds of fusion since the 
assay runs down relatively fast. Since the antibodies block disassembly of the SNARE 
complex by NSF/α-SNAP, given a stable system that monitors release for many rounds of 
exo-endocytosis, a phenotype similar to the comatose mutation in Drosophila (Pallanck et 
al., 1995)  would probably be discernible.  
The final experiments dealt with determining the status of SNARE complexes in 
resting and stimulated pre-synaptic nerve terminals. Interestingly, the total amount of 
SNARE complex in both the resting and the stimulated synaptosomes was comparable, 
indicating that SNARE complexes are rapidly disassembled after exocytosis has occurred. 
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complexes un-disassembled. Indeed, imaging of isolated vesicles indicated that a majority 
of the vesicles carried a few copies of cis-SNARE complexes. These findings were 
substantiated by immunoblots of sub-cellular fractions of the rat brain showing significant 
amount of SNARE complexes in the vesicular fractions. However, it cannot be ruled out 





































Abbreviations and Symbols 
 114
 
Abbreviations and symbols 
 
Å   Angstrom 
aa   Amino acid 
APS   Ammonium persulfate 
ATP   Adenosine triphosphate 
a.u.   Arbitrary units 
BSA   Bovine serum albumine 
cmc   Critical micelle concentration 
DOPS   1,2-Dioleoyl-sn-Glycero-3-(Pospho-L-Serine)  
DTT   Dithiothreitol 
DNA   Deoxyribonucleic acid 
E.coli   Escherichia coli 
EDTA   Ethylendiaminetetraacetic acid 
EPR   Electron paramagnetic resonance 
FFF   Free flow fractionation 
FRET   Förster resonance energy transfer 
GST   Glutathion-S-transferase 
GTP   Guanosine triphosphate 
GTPase  GTP hydrolysing enzyme 
IgG   Immunoglobulin G 
IPTG   Isopropyl-β-D-thiogalactoside 
kDa   Kilo Dalton 
LB   Luria Bertani medium 
mS   Milli Siemens 
MWCO  Molecular weight cut off 
NEM   N-ethyl-maleimide 
Ni-NTA  Nickel-nitrilo-triacetate 
NSF   N-ethylmaleimide-sensitive factor 
PAGE   Polyacrylamide gel electrophoresis 
PBS   Phosphate buffered saline 
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PMSF   Phenymethylsulfonylflouride 
POPC  1-Palmitoy-2-Oleoyl-sn-Glycero-3-Phosphocholine 
pH   Negative logarithm of H+ concentration 
rpm   Revolutions per minute 
RT   Room temperature 
S   Svedberg 
SDS   Sodium dodecyl sulfate 
SEM   Standard error of the mean 
SD   Standard deviation 
SNAP   Soluble-NSF-attachment protein 
SNAP-25  Synaptosome associated protein of 25 kDa 
SNARE  SNAP-receptor 
TB   Terrific broth 
TEMED  N,N,N’,N’-Tetramethylethylene diamine 
Tris   Trisand -aminomethane 
V/v   Volume/volume 
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